Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure
Bitcoin is showing renewed strength after reclaiming the $70,000 level, a move that has helped stabilize sentiment following weeks of heightened volatility and uncertain market direction. The recovery comes as several structural indicators begin to shift in favor of a more constructive market environment, suggesting that the recent correction may be transitioning into a new phase.
According to analysis from Axel Adler, multiple regime and structural indicators have moved into positive territory simultaneously for the first time in nearly three months. The report highlights the behavior of the Bitcoin Regime Score, an aggregated metric that incorporates several market variables, including taker imbalance, open interest pressure, funding rates, ETF flows, exchange flows, and price trend. The score is normalized on a scale ranging from -100 to +100 to identify shifts in market regimes.
On February 7, the Regime Score dropped to -47, marking the deepest bearish reading recorded over the past year. For comparison, the market bottom in November 2025 reached -37 and required 33 days to recover to neutral territory, while the August low of -35 reversed in only 11 days.
Bitcoin Regime Score | Source: CryptoQuant In the current cycle, however, the recovery has occurred in approximately 25 days. As of March 4, the indicator has climbed back to around +0.98, signaling a potential transition away from the recent bearish regime.
Structural Indicators Align As Bitcoin Tests Key Resistance Adler further notes that price-based structural signals are now aligning with regime indicators, reinforcing the significance of Bitcoin’s recent recovery above $70,000. One of the key metrics highlighted in the report is the Structure Shift Composite, a fast signal designed to capture short-term changes in market structure.
The Structure Shift Composite ranges from -1 to +1 and incorporates several elements of price behavior, including momentum, the sequence of price movements, and the asset’s position relative to its exponential moving averages. At the same time, the Donchian Channel provides a framework for identifying current technical boundaries, placing resistance near $73,698 and support around $62,981.
Bitcoin Price Structure | Source: CryptoQuant Earlier in the cycle, the relationship between these indicators followed a different pattern. In January, the Structure Shift signal crossed above zero in a single sharp move—from -0.05 to +0.57—on January 2, but only after the Regime Score had already been firmly in bullish territory for several days. That confirmation was followed by a rally that eventually pushed Bitcoin toward the $97,000 region.
The current transition has developed differently. Between March 2 and March 4, both Structure Shift and the Regime Score crossed into positive territory simultaneously. With Structure Shift now near +0.56 and Regime Score at +0.98, this synchronized shift suggests that the recent move toward $73,000 may represent a broader structural transition rather than a temporary short squeeze.
Bitcoin Attempts Recovery Above Long-Term Support The weekly chart shows Bitcoin trading near $72,800 after staging a rebound from the sharp correction that pushed the asset below the $65,000 region earlier in 2026. Following a prolonged rally that carried BTC above $110,000 in late 2025, the market entered a corrective phase marked by lower highs and increasing volatility.
BTC testing critical price level | Source: BTCUSDT chart on TradingView The recent decline briefly forced Bitcoin below its 50-week moving average, a level that had previously acted as dynamic support throughout much of the bull cycle. However, the latest weekly candle suggests that buyers are attempting to reclaim this level, which now sits near the $70,000 region. Holding above this area is technically significant, as it often serves as a structural pivot during mid-cycle consolidations.
Below the current price, the 100-week moving average is positioned around the mid-$60,000 zone, while the 200-week moving average continues to trend upward near the high-$50,000 region. These levels form a broader long-term support cluster that could help stabilize the price if volatility returns.
From a structural perspective, Bitcoin remains within a macro uptrend despite the recent correction. The market is now attempting to form a higher low relative to the 2024–2025 advance.
If BTC successfully consolidates above $70,000, the next resistance region could emerge near $85,000, where the previous breakdown accelerated earlier this year.
Featured image from ChatGPT, chart from TradingView.com
Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.
Sign Up for Our Newsletter! For updates and exclusive offers enter your email.
Sebastian's journey into the world of crypto began four years ago, driven by a fascination with the potential of blockchain technology to revolutionize financial systems. His initial exploration focused on understanding the intricacies of various crypto projects, particularly those focused on building innovative financial solutions. Through countless hours of research and learning, Sebastian developed a deep understanding of the underlying technologies, market dynamics, and potential applications of cryptocurrencies. As his knowledge grew, Sebastian felt compelled to share his insights with others. He began actively contributing to online discussions on platforms like X and LinkedIn, focusing on fintech and crypto-related content. His goal was to expose valuable trends and insights to a wider audience, fostering a deeper understanding of the rapidly evolving crypto landscape. Sebastian's contributions quickly gained recognition, and he became a trusted voice in the online crypto community. To further enhance his expertise, Sebastian pursued a UC Berkeley Fintech: Frameworks, Applications, and Strategies certification. This rigorous program equipped him with valuable skills and knowledge regarding Financial Technology, bridging the gap between traditional finance (TradFi) and decentralized finance (DeFi). The certification deepened his understanding of the broader financial landscape and its intersection with blockchain technology. Sebastian's passion for finance and writing is evident in his work. He enjoys delving into financial research, analyzing market trends, and exploring the latest developments in the crypto space. In his spare time, Sebastian can often be found immersed in charts, studying 10-K forms, or engaging in thought-provoking discussions about the future of finance. Sebastian's journey as a crypto analyst and investor has been marked by a relentless pursuit of knowledge and a dedication to sharing his insights. His ability to navigate the complex world of crypto, combined with his passion for financial research and communication, makes him a valuable asset to the industry. As the crypto landscape continues to evolve, Sebastian remains at the forefront, providing valuable insights and contributing to the growth of this revolutionary technology.
2026-03-06 08:105d ago
2026-03-06 02:025d ago
Bitcoin exchange reserves just hit a level not seen since the Trump midterms
The amount of Bitcoin sitting on centralized exchanges just dropped below 2.708 million BTC. That’s the lowest reserve level since November 2018, when Donald Trump was dealing with midterm election results and Bitcoin was trading under $4,000.
Back then, low exchange reserves meant nobody cared enough to trade. Today, it likely means the opposite — holders are pulling coins into cold storage and refusing to sell.
What the numbers actually mean Exchange reserves track how much Bitcoin is held in wallets controlled by centralized platforms like Coinbase, Binance, and Kraken. When the number drops, it typically signals that investors are moving BTC off exchanges and into self-custody.
In English: fewer coins available for immediate sale means less liquid supply. And less liquid supply, when demand holds steady or rises, tends to push prices higher.
The data, flagged by on-chain analyst Gloria Crypto, shows reserves crossing below the 2,708,000 BTC threshold for the first time in nearly seven years. To put that in perspective, exchanges held roughly 3.2 million BTC at their peak in early 2020. That’s a drawdown of roughly 500,000 BTC — worth approximately $52B at current prices.
Bitcoin is currently trading near $104K, which makes this supply squeeze feel materially different from the 2018 version. Seven years ago, the market was in a brutal bear cycle. Exchange balances were low because retail had capitulated and institutional interest was essentially nonexistent.
Today’s low reserves come amid all-time-high price territory, spot ETF inflows, and corporate treasury adoption led by companies like Strategy (formerly MicroStrategy). The context could not be more different.
Why coins are leaving exchanges Several forces are pulling Bitcoin off trading platforms simultaneously.
First, spot Bitcoin ETFs in the US have been absorbing supply at a steady clip since their January 2024 launch. BlackRock’s iShares Bitcoin Trust (IBIT) alone holds over 300,000 BTC. Those coins sit in institutional custody, not on exchange order books.
Second, corporate treasuries keep stacking. Strategy now holds more than 568,000 BTC, and a growing list of public companies — from Metaplanet in Japan to Semler Scientific in the US — are following the playbook. Every corporate purchase removes coins from circulating exchange supply.
Third, long-term holders appear increasingly unwilling to part with their Bitcoin. On-chain metrics consistently show that coins held for more than a year represent a growing share of total supply. Conviction, it turns out, looks a lot like stubbornness on a blockchain.
What this means for investors Declining exchange reserves are generally considered a bullish structural signal, but they come with nuance. Lower liquidity can amplify moves in both directions. If a large seller suddenly needs to liquidate, thin order books mean the price impact could be severe.
That said, the current trend suggests the market’s available float is shrinking while demand channels — ETFs, corporate buyers, sovereign wealth interest — continue expanding. It’s the kind of supply-demand imbalance that technical analysts dream about and short sellers lose sleep over.
The historical parallel worth watching: in late 2020, exchange reserves began a similar steep decline. Bitcoin went from roughly $10K to $64K over the following six months. Past performance guarantees nothing, but the structural setup rhymes.
Investors should also consider that exchange reserve data isn’t perfectly transparent. Different analytics platforms use varying methodologies to attribute wallets. The directional trend, however, is consistent across providers — reserves are falling, and they’ve been falling for years.
Risk factors remain real. Regulatory shifts, macroeconomic shocks, or a sudden unwinding of leveraged positions could trigger forced selling that temporarily overwhelms the supply picture. A shrinking float is a tailwind, not a guarantee.
Bottom line: Bitcoin’s exchange supply just hit a nearly seven-year low while the price hovers near six figures. Whether you read that as a coiled spring or a fragile equilibrium probably depends on your time horizon — but the market hasn’t looked this structurally tight since most people had never heard of DeFi.
Disclosure: This article was edited by Estefano Gomez. For more information on how we create and review content, see our Editorial Policy.
2026-03-06 08:105d ago
2026-03-06 02:045d ago
Pi Network Price Rallies After Major Upgrade Update: Can PI Coin Reclaim $0.35?
Pi Network price is showing fresh signs of strength after weeks of consolidation, rising more than 10% in the past 24 hours and reclaiming the $0.19–$0.20 zone. The rebound comes as the broader crypto market attempts to stabilize, but a key catalyst appears to be emerging from within the Pi ecosystem itself.
2026-03-06 08:105d ago
2026-03-06 02:255d ago
Culper Research shorts Ether, warns of Ethereum ‘death spiral'
Short-selling firm Culper Research says it has taken a bearish position against Ethereum’s native token and companies closely tied to it, arguing that the blockchain’s economic model is deteriorating following recent network changes.
Summary
Culper Research disclosed a short position against ether and ETH-linked stocks, including BitMine. The firm argues Ethereum’s fee revenue has collapsed, weakening the network’s economic incentives. Culper claims some network activity metrics may be inflated by spam transactions such as address-poisoning and dusting. Short seller Culper targets Ethereum and BitMine in bearish report In a report published March 5, Culper disclosed it is shorting Ethereum (ETH) as well as equity linked to the asset, including BitMine Immersion Technologies, a firm that has built a large treasury position in the cryptocurrency.
The report argues that Ethereum’s recent upgrades, designed to increase block capacity and reduce transaction costs, have had an unintended consequence: sharply reducing fee revenue that supports the network’s validator incentives.
Culper said Ethereum’s fee generation has collapsed in recent months, undermining the narrative that the network’s tokenomics are strengthening over time.
Ethereum’s fee revenue has collapsed, and with it the economic engine that once justified ETH’s valuation, the report stated.
According to the firm, the drop in fees is eroding staking yields for validators, potentially weakening long-term incentives to secure the network. Culper described the dynamic as a possible “death spiral,” in which falling economic rewards discourage participation while further undermining network security and investor confidence.
The report also singles out BitMine, which has accumulated millions of dollars worth of ether as part of a corporate treasury strategy. Culper argues the company’s valuation is heavily tied to the price of ETH and could face significant downside if the cryptocurrency continues to struggle.
Culper’s report also highlights recent on-chain transactions from wallets associated with Buterin, arguing that the Ethereum co-founder has sold tens of thousands of ETH this year, which the firm says undermines bullish narratives around the asset.
“Vitalik is selling, while bulls like Tom Lee are clueless as to ETH’s new reality,” the report said. “We’re with Vitalik.”
Culper also pushed back on bullish interpretations of rising Ethereum transaction counts and address activity, arguing that some of the increase may stem from spam-like on-chain activity such as address-poisoning or dusting transactions rather than organic user growth.
The short thesis arrives amid a period of volatility for crypto markets, with Ether and other major digital assets facing renewed scrutiny over their long-term economic models as scaling upgrades and layer-2 adoption reshape the blockchain ecosystem.
2026-03-06 08:105d ago
2026-03-06 02:265d ago
Bitcoin Reserves on CEXes Collapse to Lowest Level Since November 2018
The supply of Bitcoin held on centralized crypto exchanges (CEXes) has experienced a massive decline, according to the latest onchain data provided by analytics firm CryptoQuant.
Bitcoin exchange reserve across all platforms has nose-dived below 2,708,000 BTC. This is the lowest level of exchange liquidity the market has seen since November 2018.
The leading cryptocurrency is currently hovering slightly above the $70,000 level.
HOT Stories
The great coin exodus There is now a clear multi-year divergence between Bitcoin's price and the balances held on centralized exchanges.
Exchange reserves peaked at over 3.5 million BTC during the height of the previous bull cycles between 2020 and 2022.
card
However, following a series of industry crises in late 2022, the current persistent trend was set into motion.
Throughout 2023, 2024, and into early 2026, the blue line has been on a downward trajectory.
Exchange reserves have bled out to the current 2.7 million BTC level while the price of Bitcoin has climbed back toward all-time highs.
The days of users keeping their portfolios idle on trading platforms appear to be effectively over.
The approval and massive success of U.S. spot Bitcoin ETFs have significantly changed the supply dynamics. Institutional funds are sweeping up billions of dollars worth of BTC from the open market.
Corporate hoarding is also a significant factor, with major corporate treasuries of the likes of Strategy Inc. (MSTR) aggressively accumulating and holding BTC on their balance sheets.
The market is facing a typical liquidity crunch, which could potentially set the stage for a "supply shock."
2026-03-06 08:105d ago
2026-03-06 02:365d ago
Bitcoin (BTC) Price Retreats to $70K as Geopolitical Tensions and Failed Rally Spark Concerns
Key Takeaways BTC declined 3.1% to approximately $70,182 during Friday’s Asian session The cryptocurrency momentarily reached a four-week peak of $74,000 Thursday before reversing course CryptoQuant’s Bull Score Index registers merely 10 out of 100, indicating deep bearish conditions The rejection at $74,000 has market participants monitoring $60,000 as critical support American institutional demand has strengthened, though macroeconomic headwinds persist Bitcoin experienced a significant retreat Friday following a brief surge to $74,000 the previous day, sliding to approximately $70,182 in Asian market hours.
Bitcoin (BTC) Price The approximately 3.1% decline followed Bitcoin’s achievement of a four-week high on Coinbase Thursday, momentarily touching the 50-day exponential moving average before encountering selling pressure.
Despite the retracement, Bitcoin maintains a weekly increase of roughly 7%.
Escalating geopolitical tensions contributed to market stress. Coordinated US and Israeli military operations against Iran prompted retaliatory responses involving missiles and drones, with hostilities now extending into their seventh consecutive day.
The ongoing conflict has intensified concerns regarding petroleum supply routes through the Strait of Hormuz, a critical waterway responsible for approximately 20% of worldwide oil transportation. Crude oil valuations surged over 16% throughout the week.
Elevated petroleum prices have amplified inflation anxieties, consequently diminishing market expectations for Federal Reserve monetary policy easing. This dynamic bolstered the US dollar, exerting downward pressure on risk-sensitive assets like Bitcoin.
Bearish Indicators Persist Blockchain analytics provider CryptoQuant indicated Thursday that Bitcoin continues to exhibit bear market characteristics, notwithstanding the temporary price recovery.
Their proprietary Bull Score Index, which synthesizes fundamental and technical indicators, currently registers just 10 out of 100. The analytics firm characterized the recent advance as “likely just a relief rally, not the start of a new bull phase.”
Source: CryptoQuant Nick Ruck, director at LVRG Research, attributed the rally to revitalized risk appetite and exchange-traded fund capital inflows, though noted it “quickly faced headwinds” as macroeconomic uncertainty and deteriorating momentum pressured valuations downward.
Technical Analysis Suggests Downside Risk From a technical perspective, Bitcoin validated what market participants describe as a “failed auction” at the $74,000 resistance threshold. Price action briefly penetrated this level before sharply reversing and settling back beneath it.
This price point coincided with the volume-weighted average price (VWAP), establishing a dual resistance configuration that ultimately proved insurmountable.
With the value area high now compromised, market observers suggest a trajectory toward $60,000 — the prior weekly low — becomes increasingly probable should selling pressure intensify.
Analysts at SwissBlock stated Friday that “momentum is flashing a critical shift,” noting Bitcoin is “exiting peak negative momentum.”
Regarding demand dynamics, CryptoQuant observed a positive Coinbase Premium, indicating renewed acquisition activity from American institutional participants. Bitcoin spot demand from US market participants transitioned from contraction to expansion.
Distribution pressure from active traders and long-term position holders has diminished following unrealized losses reaching magnitudes last observed in July 2022.
Bitwise Asset Management disclosed a $233,000 contribution to Bitcoin open-source development initiatives, marking its second annual allocation linked to its spot Bitcoin ETF performance.
Bitcoin was exchanging hands near $70,182 during early Friday trading.
2026-03-06 08:105d ago
2026-03-06 02:405d ago
Bitcoin Drops Then Rebounds Amid Global Instability
Military strikes involving the United States, Israel, and Iran have revived global market nervousness, triggering an immediate bitcoin reaction. Some analysts see a scenario reminiscent of 2022, supported by charts. However, the comparison deserves to be nuanced. While technical similarities emerge, the macroeconomic context and market structure differ significantly. In this geopolitical uncertainty climate, analyzing bitcoin movements helps better measure immediate risks and resilience margins of the crypto ecosystem.
In brief Military tensions between the United States, Israel, and Iran trigger an immediate shockwave on global financial markets and on bitcoin. The crypto market enters a phase of high volatility marked by a rapid price drop and massive liquidations of positions. After the initial correction, a technical rebound begins, reflecting resistance capacity despite a tense geopolitical climate. Flows toward financial products related to bitcoin support demand, while commodity volatility weighs on all risky assets. Markets and bitcoin facing the geopolitical shock The intensification of military tensions involving the United States, Israel, and Iran quickly contaminated global financial markets. Investors adjusted their positions in response to a rise in geopolitical risk, causing sharp moves in assets sensitive to external shocks, including bitcoin.
The crypto market thus recorded a sequence of high volatility concentrated over a few sessions, marked by rapid declines, massive liquidations, and increased monitoring of technical thresholds. These reactions reflect a tension phase where risk exposure management dominates investment strategies.
Bitcoin dropped to nearly $63,000 during a turbulent weekend, following coordinated strikes against Iran that “shook investor confidence in risk-sensitive assets” ; Over $300 million in long positions were liquidated in the crypto market at the start of the tensions, illustrating the extent of the selling movement ; Several technical analysts identified a major support level around $60,263, a threshold considered decisive for short-term market stability. A market under watch : between volatility and opportunities As the week progresses, bitcoin shows signs of recovery after its initial correction. Market data shows that the price rebounded to temporarily exceed $71,000, illustrating some resistance in the market’s high zone despite persistent geopolitical tensions. This rebound comes as some major exchanges display a moderate reaction to economic news related to the conflict, temporarily reducing the impact on crypto assets.
Other factors fuel this dynamic. Interest in financial products linked to bitcoin, such as Bitcoin ETFs, continues to attract significant flows, which could help support demand despite the adverse environment. Meanwhile, some analysts note that rising volatility in commodities like oil and metals could spill over into the stock market, and by extension on cryptos if this volatility amplifies, creating a tougher context for risky assets.
These developments reveal several possible scenarios for bitcoin in the coming weeks. If tensions continue to rise, pressure on markets could intensify capital movements toward traditional safe-haven assets like gold, while forcing more volatile assets to suffer from temporary disengagement. Conversely, bitcoin’s ability to stabilize and attract institutional flows, even during a complex geopolitical period, could signal increased market maturity.
Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.
Join the program
A
A
Lien copié
Luc Jose A.
Diplômé de Sciences Po Toulouse et titulaire d'une certification consultant blockchain délivrée par Alyra, j'ai rejoint l'aventure Cointribune en 2019. Convaincu du potentiel de la blockchain pour transformer de nombreux secteurs de l'économie, j'ai pris l'engagement de sensibiliser et d'informer le grand public sur cet écosystème en constante évolution. Mon objectif est de permettre à chacun de mieux comprendre la blockchain et de saisir les opportunités qu'elle offre. Je m'efforce chaque jour de fournir une analyse objective de l'actualité, de décrypter les tendances du marché, de relayer les dernières innovations technologiques et de mettre en perspective les enjeux économiques et sociétaux de cette révolution en marche.
DISCLAIMER
The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.
2026-03-06 08:105d ago
2026-03-06 02:415d ago
TRON Price Bounces as SEC Drops Lawsuit Against Founder Justin Sun
The price of TRON has seen some gains despite the overall decline in the cryptocurrency market. This comes after the news that the SEC dropped their lawsuit against Toncoin founder Justin Sun.
Justin Sun Gets Lawsuit Dismissed as TRON Price Rebounds The US SEC has made an announcement that it will be dismissing its lawsuit against cryptocurrency billionaire Justin Sun. In addition, a company associated with him will be paying $10 million as a settlement. This is as they look to settle a series of cases related to digital assets, which were initiated by President Biden.
The news regarding the Justin Sun lawsuit caused a bump in the price of TRON, as per CoinMarketCap. The coin moved from the red zone to increase in price to $0.2858. This is despite the fact that the price of Bitcoin is down by 3%.
Justin Sun and his companies, Tron Foundation, BitTorrent Foundation, and Rainberry have not admitted to any wrongdoing, as per a letter by the SEC. Sun has expressed how happy he is that the SEC has agreed to dismiss the charges against him.
The SEC had filed a lawsuit against Sun and his companies in March 2023 over their plan to distribute Tronix and Bittorrent, which is illegal.
The founder of Tron allegedly accumulated $31 million in ill-gotten gains through the scheme when he instructed his employees to trade hundreds of thousands of tronix tokens in two of his accounts to give the appearance that the trades were legitimate.
The SEC agreed to drop all the allegations against Justin Sun as per the proposed plan to settle the lawsuit. The lawyer representing the SEC referred to the proposed settlement as “fair and reasonable.” Rainberry will pay a civil penalty of $10 million once it is approved by the Judge.
Warren Again Accuses Trump of Bias Immediately after the news, Senator Elizabeth Warren accused President Donald Trump of favoritism towards certain entities.
“Last month, SEC Chair Atkins denied in front of Congress that the Trump Administration is giving a free pass to crypto billionaires with ties to Donald Trump. Justin Sun poured $90 million into Trump’s crypto ventures, and today the SEC agreed to drop its case against him,” she said.
Warren also shared her issues of concern over the crypto market bill. According to the Democrat Senator, this will only promote the crypto corruption practices of the President.
Despite the lawsuit, Justin Sun had bought a number of coins belonging to the Trump family. Since then, he has returned to the US and was also invited to dinner with the President just because he bought the TRUMP coin.
2026-03-06 08:105d ago
2026-03-06 02:445d ago
XRP Holds the Line at $1.40 as Breakout Pressure Reaches Boiling Point
XRP Holds the Line at $1.40 as Final Compression Signals Potential Breakout Toward $3XRP is demonstrating strong resilience as it continues to hold a crucial support level, signaling the potential for a significant price move ahead.
According to market analyst Crypto Paykash, the asset has consistently defended the key $1.40 support zone, a level closely watched as a base for its next major breakout.
Data from CoinCodex reinforces this outlook, showing that XRP has repeatedly maintained this price floor despite wider market volatility, suggesting growing stability and the possibility of building bullish momentum.
Source: CoinCodexThe $1.40 level has solidified as XRP’s key defensive line, repeatedly attracting strong buying pressure whenever the price tests it.
Each rebound from this zone highlights growing conviction among traders and long-term holders, suggesting the area is widely viewed as a high-value accumulation point rather than a breakdown trigger.
Meanwhile, XRP’s realized volatility has surged to its highest level since March 2025, coinciding with aggressive whale activity. Large holders accumulated 1.3 billion XRP within just 48 hours, a move that historically signals preparation for a significant market shift.
Together, the persistent defense of the $1.40 support and the sharp rise in whale accumulation point to intensifying market compression, conditions that often precede a major price expansion.
Well, As long as the $1.40 support continues to hold, bullish momentum remains intact while the tightening range signals building pressure in the market. This compression suggests a breakout may be imminent.
A decisive reclaim of the $1.80–$2.00 resistance zone would confirm renewed strength and could trigger the next rally phase, potentially propelling XRP toward the $3 level sooner than many expect.
More importantly, XRP’s price action is forming what analyst Paykash describes as a compression pattern, a technical structure where price consolidates within an increasingly narrow range. Such formations often indicate that volatility is quietly building beneath the surface, typically preceding a sharp and decisive breakout once the range finally resolves.
XRP Compression Nears Breaking Point as $3 Target Comes Into FocusPaykash notes that XRP’s compression pattern is nearing its final stage, signaling a potential swift and decisive breakout that could catch sidelined traders off guard.
The next critical hurdle lies in the $1.80–$2.00 resistance zone, amid growing debate on whether XRP is entering a high-stakes distribution or strategic repositioning phase.
A confirmed breakout above $2.00 could ignite fresh momentum across the market, potentially propelling XRP toward $3.00 in a rapid surge. Such a move would signal a strong recovery, drawing renewed interest from traders aiming to ride the next uptrend.
Meanwhile, Moscow Exchange is considering cash-settled XRP futures following Russia’s recent regulatory shift, keeping the market in a cautious, watchful phase.
With support at $1.40 holding firm and resistance near $2.00 tightening, XRP’s compression pattern is building significant pressure. If this support endures, the stage is set for a potential explosive breakout, bringing the $3 level squarely into view.
ConclusionXRP’s current price structure signals that the market is nearing a critical inflection point. As long as the $1.40 support level holds, bullish momentum remains intact, with the tightening compression pattern indicating that a decisive move may be imminent.
A strong reclaim of the $1.80–$2.00 resistance zone would confirm renewed buying strength and could trigger the next major rally. If this breakout materializes, XRP may quickly target higher levels, potentially accelerating toward the $3 mark.
2026-03-06 08:105d ago
2026-03-06 02:465d ago
Cardano price prediction as ADA accepted at 137 Spar stores in Switzerland
Cardano’s native token ADA is drawing renewed attention after the Cardano Foundation announced that the cryptocurrency can now be used for payments at Spar supermarkets across Switzerland, marking a real-world adoption milestone for the blockchain network.
Summary
Cardano Foundation announced that Cardano can now be used at 137 stores of SPAR in Switzerland, expanding real-world crypto payment adoption. ADA is trading near $0.27 after weeks of consolidation following a broader downtrend from the $0.40 region earlier this year. Technical indicators show weak accumulation and slightly bearish momentum, with key support around $0.26 and resistance near $0.30. According to the foundation, customers can now pay with the Cardano token (ADA) using a crypto payment integration powered by the OpenCryptoPay gateway, allowing seamless checkout transactions in participating stores.
The rollout makes the Swiss branch of the global retail chain one of the largest supermarket networks in Europe to accept ADA payments.
You can now pay with $ADA at 137 SPAR stores across Switzerland.
In partnership with @DFX_swiss and @BrickTowers, we are helping bring blockchain into everyday commerce through real-time, low-cost retail payments.
Read the full press release: https://t.co/gvYRHclp4F
— Cardano Foundation (@Cardano_CF) March 5, 2026 The initiative reflects Cardano’s broader push toward everyday payment use cases and could help strengthen the network’s reputation as a practical blockchain ecosystem beyond decentralized finance and token speculation.
Retail adoption has historically been a positive sentiment driver for cryptocurrencies, as it signals growing real-world utility. However, the impact on price tends to depend on broader market conditions and investor demand rather than adoption announcements alone.
At press time, ADA is trading near $0.27, showing modest stabilization after a prolonged downtrend that began in early January.
Cardano price prediction after ADA payment rollout across Spar stores The daily chart shows that Cardano has been trading in a tight consolidation range between $0.26 and $0.30 over the past few weeks following a steep decline from the $0.40 region earlier in the year.
ADA price analysis | Source: Crypto.News Price is currently hovering around $0.269, with the market forming smaller candles and reduced volatility — a pattern that often precedes a breakout move.
The Accumulation/Distribution indicator, sitting near 50.66B, has been trending slightly downward, suggesting that buying pressure remains limited and that large investors have not yet begun aggressive accumulation.
Meanwhile, the Balance of Power (BOP) indicator remains marginally negative at -0.0097, indicating that sellers still hold a slight advantage in the short term.
Key levels to watch include support near $0.26, which has held multiple times since mid-February. A breakdown below this level could expose ADA to further downside toward $0.24.
On the upside, resistance sits around $0.30, with a stronger barrier near $0.32. A sustained break above these levels could signal the start of a recovery rally if bullish momentum returns to the broader crypto market.
For now, ADA appears to be in a consolidation phase, with traders watching for a catalyst — such as increased adoption or broader market strength — to determine the token’s next major move.
Key Takeaways Ethereum declined 6% following a brief rally to $2,200, pressured by US equity market weakness and geopolitical tensions Options market skew reached 7%, indicating institutional traders are positioning for potential downside US spot Ethereum ETFs experienced combined net outflows totaling $91 million on March 5 The validator entry queue expanded to 3.4 million ETH, while exit queue contracted to only 58,944 ETH Ethereum commands 65% of aggregate blockchain TVL across layer-1 and layer-2 networks, with $55.4B on mainnet Ethereum is currently exchanging hands near $2,080 following its inability to sustain momentum beyond the $2,200 threshold this week. The pullback occurred amid deteriorating global market conditions, influenced by escalating Middle East tensions and a US judicial decision mandating government repayment exceeding $130 billion in tariff refunds to domestic enterprises.
Ethereum (ETH) Price The second-largest cryptocurrency had mounted an impressive 22% recovery from its February nadir of $1,800, but upward momentum dissipated rapidly. Wednesday’s temporary breach of $2,200 was swiftly followed by a 6% retracement, echoing broader risk-asset selloffs across US markets.
Futures market indicators paint a cautious picture. The 30-day annualized premium for ETH futures contracts remains significantly below the 5% neutral benchmark, suggesting limited appetite for leveraged bullish positions among derivatives traders.
The put-call skew for ETH options expanded to 7% on Thursday. Historical patterns indicate that readings exceeding 6% generally reflect heightened demand for downside protection among sophisticated market participants.
Liquidation data from CoinGlass reveals that ETH traders absorbed $58 million in forced position closures over a 24-hour period, with long positions accounting for $35.7 million of that total.
Institutional Flows and Staking Dynamics The price deterioration coincided with unfavorable institutional flow data. March 5 witnessed US spot Ethereum ETF products recording aggregate net redemptions of $91 million, signaling a temporary retreat in institutional demand.
This outflow represented a sharp reversal from the more constructive inflows observed during earlier trading sessions in the week, underscoring how rapidly institutional sentiment responds to changing market dynamics.
Meanwhile, network staking metrics present a contrasting narrative. The validator activation queue has ballooned to approximately 3.4 million ETH, while the corresponding exit queue has diminished to merely 58,944 ETH. Prospective validators now face wait times approaching 57 days.
These figures indicate that substantial holders are preferring to stake their ETH for yield generation rather than liquidating positions during market turbulence.
Onchain Metrics and Ecosystem Dominance Decentralized exchange activity on Ethereum has cooled considerably. Weekly DEX trading volumes contracted to $12.6 billion from $20.2 billion recorded one month prior. Decentralized application revenues similarly declined to $14.1 million over the trailing seven days, representing a 47% month-over-month decrease.
Solana experienced comparable trends, with DEX volumes contracting by 50% across the identical 30-day measurement period.
Source: DefiLlama Notwithstanding reduced network activity metrics, Ethereum maintains its commanding position in value locked across the blockchain ecosystem. When accounting for layer-2 scaling solutions, the Ethereum infrastructure captures approximately 65% of total blockchain TVL. The mainnet alone secures $55.4 billion, substantially exceeding Solana’s $6.8 billion.
Technical analysis identifies immediate resistance at the $2,108 level on daily timeframes. A decisive close above this threshold could facilitate a move toward $2,388. Conversely, should support at $1,741 fail to hold, subsequent downside targets emerge at $1,524 and $1,404.
Analysts have identified $1,826 as the lower boundary of the current range structure, representing the next technical attractor should selling pressure intensify in the near term.
2026-03-06 08:105d ago
2026-03-06 03:005d ago
Ethereum ETFs Record Best Single-Day Performance Since January With $169M Inflows
As the crypto market bounces from the latest shakeout, Ethereum (ETH) and investment products based on the King of Altcoins recorded a remarkable single-day performance, potentially setting the stage for further recovery.
Ethereum ETFs Recover Amid Market Bounce Ethereum-based spot Exchange-Traded Funds (ETFs) recovered from Tuesday’s weak performance and recorded their best single-day in nearly two months, with $169 million in inflows on Wednesday.
According to SoSoValue data, the category saw the highest netflow since January 14, when it drew in $175 million. Notably, the mid-January crypto market correction triggered massive outflows for investment products, with funds based on the two largest crypto assets, Bitcoin (BTC) and ETH, showing the weakest performance.
Ethereum ETFs saw a five-week negative streak, bleeding $1.38 billion during this period. However, the funds ended their weekly outflow run last week after posting inflows worth $80.46 million.
Ethereum ETFs recover from one-month outflow streak. Source: SoSoValue So far, the products have drawn in $197.35 million this week, potentially setting a base to register their best weekly performance since January 16, when it closed the week with $479.04 million.
Alex Kuptsikevich, chief market analyst at FxPro, recently highlighted that the strength of crypto ETFs, despite growing geopolitical tensions and financial markets’ selloff, could be seen as “a victory for cryptocurrencies,” suggesting that some traders may be considering digital assets as a safe haven.
Meanwhile, James Butterfill, head of research at CoinShares, emphasized that “recent client discussions have been almost entirely focused on identifying entry points rather than reducing exposure to the asset class.”
ETH At A Structural Decision Point Ethereum’s price climbed 12% on Wednesday, its highest level since February 4. Amid the market recovery, the cryptocurrency reclaimed the $2,100 barrier and reached a one-month high of to $2,199 before retracing.
The king of altcoins has been trading between the $1,825-$2,150 levels since the early February breakdown, unable to break past the upper boundary of its local range.
Analyst Rekt Capital pointed out that ETH closed the month just below a crucial multi-year ascending trendline, which has served as macro support and a decisive directional point over the years.
ETH risks a monthly retest of the multi-year trendline as resistance. Source: Rekt Capital This places the price in a structurally bearish position, as it enables a monthly retest of this level as resistance instead of support. The analyst emphasized that if this trendline becomes a resistance, it would confirm a breakdown from the macro structure and increase the likelihood of a deeper move into a key horizontal zone and historical demand cluster situated around the $1,600 region.
“If Ethereum rejects from the trendline and the current bounce retraces in full, that rejection would signal the trendline dissipating as support and confirm the breakdown scenario,” he stated.
However, he noted that bearish continuation is not confirmed yet, explaining that if ETH manages to reclaim the trendline as support in the monthly timeframe, the horizontal zone and historical supply area around the $2,250-$2,500 levels could act as a relief cluster “where price may rally before the market determines its next directional move.”
“For now, Ethereum remains at a structural decision point around the multi-year trendline,” he concluded.
Ethereum’s performance in the one-week chart. Source: ETHUSDT on TradingView Featured Image from Unsplash.com, Chart from TradingView.com
2026-03-06 08:105d ago
2026-03-06 03:015d ago
Bitcoin Exchange Reserves Hit Seven-Year Low as Holders Flee Platforms
Bitcoin reserves crashed hard. CryptoQuant’s latest data shows centralized exchanges now hold just 2.7 million BTC, marking the lowest level since November 2018 when the crypto world looked completely different.
The numbers tell a pretty clear story about what’s happening right now. Investors are pulling their Bitcoin off exchanges at a pace that’s honestly kind of shocking. Many seem to think keeping their coins in private wallets beats trusting exchanges with their stash. And given what we’ve seen with hacks and regulatory pressure lately, you can’t really blame them for being cautious.
Exchange security fears are driving this exodus.
High-profile hacks keep happening, and regulators won’t stop breathing down exchanges’ necks. So holders are basically saying “thanks but no thanks” to platform storage. They’re moving coins to hardware wallets and cold storage solutions where they control the keys. It’s the old crypto saying in action – not your keys, not your coins.
The withdrawal trend isn’t just some random blip either. Whales – those big players with serious Bitcoin holdings – seem to be positioning themselves for something. Maybe they see price moves coming, or maybe they just don’t trust exchanges anymore. Either way, they’re pulling massive amounts off platforms and parking them in private wallets. Some analysts think it’s strategic, others say it’s pure fear. Probably both.
Less Bitcoin on exchanges means wilder price swings ahead. When there’s not much supply sitting on trading platforms, even small buy or sell orders can move prices hard. Traders know this, and they’re probably preparing for some serious volatility.
Other cryptocurrencies are seeing the same thing happen.
CryptoQuant’s data shows Ethereum, Solana, and other major coins are also disappearing from exchange wallets. The self-custody movement isn’t just about Bitcoin – it’s spreading across the entire crypto space. People want control over their digital assets, period.
But here’s the weird part: trading volumes are still pretty strong on these platforms. Users are still buying and selling, they just don’t want to store their coins there long-term. It’s like using a restaurant for dinner but not trusting them to store your leftovers. The business model for exchanges might need some serious rethinking. For more details, see Bitcoin Smashes ,000 Barrier as Crypto.
Binance saw its Bitcoin reserves drop significantly by March 2026. The world’s biggest crypto exchange is dealing with the same outflow problem as everyone else. Their team didn’t respond when we reached out for comment, but the numbers speak for themselves. Even the giants aren’t immune to this trend.
Coinbase reported similar issues on March 5, 2026. The company said it’s working on new security measures to keep users happy. Their spokesperson talked about transparency and trust, but actions matter more than words in crypto. Users are voting with their withdrawals.
Jesse Powell from Kraken sees opportunity in the chaos. He thinks exchanges need to diversify what they offer beyond just trading. Maybe custody services, maybe DeFi integration, maybe something completely different. Powell gets that the old playbook isn’t working anymore.
Bitcoin was trading around $42,000 on March 6, 2026. The price keeps bouncing around as traders try to figure out what declining exchange reserves mean for liquidity. Some days it pumps, other days it dumps. Typical crypto stuff, but the reserve situation adds another layer of uncertainty.
Glassnode found that addresses holding at least 1,000 BTC increased recently. The whales are accumulating while retail investors panic. These big holders probably know something the rest of us don’t, or they’re just better at timing the market. Either way, they’re hoarding Bitcoin like it’s going out of style.
Michael Saylor from MicroStrategy called the exchange exodus a sign of market maturity. He thinks institutional investors want proper custody solutions, not exchange IOUs. MicroStrategy keeps buying Bitcoin and storing it themselves, so Saylor’s putting his money where his mouth is.
Gemini launched education workshops about self-custody after the Winklevoss twins saw which way the wind was blowing. Teaching users about private keys and hardware wallets might help, but it also admits that exchanges can’t guarantee security anymore. Kind of a double-edged sword for their business. Related coverage: Bitcoin Credit Markets Get Major Overhaul.
DeFi platforms are loving this trend. Uniswap reported massive trading volume increases on March 4, 2026, as users explore decentralized alternatives. Why trust a centralized exchange when you can trade peer-to-peer? The DeFi revolution might be getting a second wind from exchange security fears.
Some exchanges won’t even comment on the reserve data. Others are scrambling to upgrade their security protocols and win back user trust. The industry is basically admitting that the old way of doing things isn’t working anymore. Adaptation or extinction – that’s the choice facing crypto exchanges right now.
The regulatory landscape keeps shifting too, making exchanges nervous about compliance costs and legal risks. Users see this uncertainty and decide self-custody looks safer than dealing with potential platform shutdowns or frozen accounts.
Bitcoin’s reserve decline hit 2.7 million BTC in March 2026.
The Federal Reserve’s recent interest rate decisions have amplified Bitcoin withdrawal patterns across major trading platforms. Rate cuts typically drive institutional money toward alternative assets, while rate hikes push investors toward safer traditional investments. This monetary policy backdrop creates additional pressure on exchange reserves as both retail and institutional players adjust their cryptocurrency exposure based on broader economic conditions.
Hardware wallet manufacturers like Ledger and Trezor reported supply shortages throughout early 2026 as demand surged. Ledger’s CEO mentioned production delays couldn’t keep pace with orders, while Trezor expanded manufacturing capacity by 40% to meet growing self-custody adoption. These companies are essentially benefiting from exchange security concerns, creating an entirely new dynamic in the crypto ecosystem where wallet makers become indirect competitors to trading platforms.
Post Views: 1
2026-03-06 08:105d ago
2026-03-06 03:045d ago
Vancouver City Staff Drops Bitcoin Reserve Plan, Says BTC Not Allowed
A proposal to make Vancouver a Bitcoin-friendly city is now facing a setback after city officials recommended cancelling the plan. Staff says local law does not allow the city to invest public funds in Bitcoin.
This puts an end to Mayor Ken Sim’s proposal to add Bitcoin to city reserves and accept crypto payments. He had even pledged to donate $10,000 in Bitcoin if the plan was approved.
Bitcoin Not an ‘Allowable Asset’ Under City LawAfter reviewing the proposal, officials working for the City of Vancouver have advised the city council to withdraw the plan to add Bitcoin to the city’s financial reserves.
City staff said that Bitcoin does not qualify as an “Allowed Investment” under the Vancouver Charter. This law decides how the city manages its money and what types of assets it is allowed to invest in.
Since Bitcoin is not on the list of approved assets, the city staff recommended ending the work on this proposal. They also suggested that the city should focus its time and resources on other projects that are a higher priority.
The recommendation came during a review of council plans. Officials looked at 181 plans made between 2018 and 2025. 103 are already finished, while the remaining 78, including the Bitcoin plan, are now being checked to decide if they should continue or be stopped
How the Bitcoin Reserve Plan Started?The proposal “Preserving the City’s Purchasing Power Through Diversification of Financial Reserves – Becoming A Bitcoin Friendly City,” was introduced by Vancouver mayor Ken Sim in November 2024.
#VanCityCouncil approves motion 3. Preserving of the City’s Purchasing Power Through Diversification of Financial Reserves – Becoming A Bitcoin Friendly City.
— Vancouver City Clerk (@VanCityClerk) December 11, 2024 Sim said that Bitcoin could help protect the city’s purchasing power over time. The plan asked city staff to study whether Vancouver could accept payments in Bitcoin and whether a small portion of the city’s financial reserves could be converted into the cryptocurrency.
The city council approved the plan in December 2024 and asked city staff to give an update by early 2025. However, no public report was shared until earlier this week.
Bitcoin’s Price Volatility Ends Vancouver’s Crypto PlanWhen Ken Sim made this proposal in December 2024, Bitcoin had just crossed $100,000 for the first time.
Now the BTC price has fallen to around $71,000. City staff in Vancouver say Bitcoin does not qualify as an “allowed investment.”
With staff now recommending that the plan be closed, Vancouver’s plan to become a Bitcoin-friendly city may soon end.
Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.
Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.
Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2026-03-06 08:105d ago
2026-03-06 03:055d ago
Will The Pressure Hold For OKB, Humanity Protocol, and Kite After Bitcoin Slips Amid Extended US-Iran War
Bitcoin on WarBitcoin faces 2% reversal from the 50-day EMA on Thursday, Slips below $71000.The surge in altcoins OKB, Human Protocol, and Kite continues to raise concerns.Wll the pressure hold for Ethereum, XRP, and these altcoins as the US -Iran War extends? Top Cryptocurrencies Bitcoin, Ethereum, and XRP showed cautious trading, with a roughly 2% pullback near their respective key support levels on Friday. BTC was trading below $71,000, ETH price remained above $ 2,000, and XRP was in sideways consolidation.
Other top-performing cryptos today are OKB (26%), Human Protocol(30%), and Kite(21%), which have spiked, making it to the top coins of the day list.
OKB Must Close Above 200-D EMA To Sustain. OKB exchange native Coin OKB moved nearly 3% since yesterday, adding to its 24% surge from the previous day. This surge was fueled by an Investment of $25B by the New York Stock Exchange’s parent company, Intercontinental Exchange.
As we see in OKB/USDT daily chart, the declining EMA’s leave a bearish sentiment. OKB coin needs a strong close above its 200D EMA level at $104 for a sustain uptrend. This closing can send it straight to its 50% Retracemenr level at $124.
OK Coin moving strongRSI at 70 shows the coin is overbought zone, but MACD is in bullish side as it crosses the Signal line and a wide histogram.
Currently trading at $97.30, with the increased positive momentum around OKB, it is going to continue the rally. If rejected at any level, it will seek the 50-d EMA as its next at $87.
Humanity Protocol Remains BullshHumanity Protocol extended roughly 4% today to its Thursday gains of 43%. The H has extended its gains above the 200-d EMA and other EMAs, eyes continue to rally as RSI at 57 has reversed from hitting the oversold zone.
HUSDT Super Stromg on ChartsH/USDT attempted the $0.2, and is likely to surpass. If invalidated, it could test $0.13 50% retracement level.
KITE Coin Bulls Are StrongKITE Coin stands as the flag bearer of AI Coin in recent trading sessions as all the AI Coins seem to be underperforming. KITE on Friday is up 25%, showing increased buyer dominance.
The KITE/USDT price chart shows its upward momentum since its launch. The asset is now extending gains above the 200-D EMA and others.
KITEUSD Super BullishOpen Interest in futures surges to 35% to $102.48 million, indicating new positions opening in parallel with the rally.
With the RSI moving toward the overbought zone, the KITE price may face rejections, but the rally continues. Invalidating this can bring it to its first resistance at $0.23.
Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.
Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.
Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2026-03-06 08:105d ago
2026-03-06 03:095d ago
Will Bitcoin price drop below $70K as $2.2B BTC options expiry looms?
Bitcoin price fell to near $70,000 on Friday following a sharp rebound the previous day. A looming BTC options expiry event is now keeping investors on edge as the market anticipates potential volatility.
Summary
Bitcoin price has given up a portion of its gains from this week. Over $2.22 billion worth of options set to expire today have spurred concerns around volatility. Bitcoin technicals remain bullish despite the current drawdown. According to data from crypto.news, Bitcoin (BTC) price fell 4.5% to an intraday low of $70,177 on Friday morning Asian time before stabilizing around $70,400 at press time. The bellwether pulled back after facing rejection around $74,000, a key resistance level it had failed to break for over a month.
Bitcoin price fell as investors began booking profits after climbing over 15% in the past 5 days.
This came amid a broader risk-off environment triggered by the ongoing war between the U.S. and Iran, which has led energy prices to soar to multi-month highs. The military escalation has also triggered capital rotation into traditional safe-haven assets, which have seen relatively better performance amid the geopolitical uncertainty.
Today, investor sentiment is being kept in check as $2.22 billion worth of Bitcoin option expiry is set to be settled on the Deribit exchange at 8:00 a.m. UTC. Over 31,500 Bitcoin open contracts are set to expire.
At press time, the put-to-call ratio was at 1.72, meaning put options or traders betting on Bitcoin to go lower far surpass the calls that are betting on a rise. The maximum pain level for BTC or the price at which most option contracts expire worthless stood at $69,000, just $1,400 short of the current spot price.
Bitcoin expiring options | Source: Deribit The maximum pain level, also known as the strike price, tends to pull spot prices towards the center around expiry. Therefore, there remains a high risk that Bitcoin price could pull back towards the $69,000 mark as options reach expiry.
Bitcoin has failed to hold above $70,000 six times since the start of February, and losing this key psychological support once again could spook short-term traders who were betting on the current recovery rally.
Bitcoin price analysis Despite the concerns surrounding the massive options expiry today, BTC price charts have not yet shown signs of a breakdown.
On the Bitcoin/USDT 24-hour chart, momentum indicators still portrayed a positive outlook at least in the short term.
Bitcoin/USDT 24-hour price chart — March 6 | Source: crypto.news Notably, the MACD line was pointing upwards, suggesting growing buying pressure for the bulls in comparison to the selling pressure exerted by bears. At the same time, the Relative Strength Index has also formed a bullish divergence with the price action.
For now, bulls will be eyeing $72,000 as the next major resistance level to claim, a break above which could likely end its downtrend today.
On the contrary, a move below the $70,000 support could pull BTC price to $69,000 and successively as low as $60,000 as the broader structure remains confined within a bearish flag pattern, which is considered one of the most negative formations in technical analysis.
Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.
2026-03-06 07:105d ago
2026-03-05 23:555d ago
DOOR Investors Have Opportunity to Lead Masonite International Corporation Securities Fraud Lawsuit
, /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of Masonite International Corporation (NYSE: DOOR) between June 5, 2023 and February 8, 2024, inclusive (the "Class Period"), of the important April 7, 2026 lead plaintiff deadline.
So What: If you sold Masonite common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
What to do next: To join the Masonite class action, go to https://rosenlegal.com/submit-form/?case_id=52802 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 7, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
Details of the case: According to the lawsuit, throughout the Class Period, defendants made material omissions and misrepresentations concerning Owens Corning's offers to purchase all of Masonite's outstanding common stock at significant premiums to Masonite's stock price and Masonite's repurchases of millions of dollars' worth of its shares without disclosing material nonpublic information about Owens Corning's offers, which, if disclosed as required, would have indicated to investors that Masonite's stock was worth significantly more.
To join the Masonite class action, go to https://rosenlegal.com/submit-form/?case_id=52802 https://rosenlegal.com/submit-form/?case_id=50622or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com
SOURCE THE ROSEN LAW FIRM, P. A.
2026-03-06 07:105d ago
2026-03-05 23:555d ago
RVT: Expensive Small-Cap Income Fund (Rating Downgrade)
Royce Small-Cap Trust has delivered a 34.7% total return over twelve months, benefiting from rotation out of large-cap tech. RVT now trades at a 6.93% discount to NAV, above its five-year average, prompting a downgrade to hold from buy. The fund maintains a 6.6% dividend yield, supported by strong net realized gains, but relies on capital gains for distributions.
2026-03-06 07:105d ago
2026-03-05 23:585d ago
Micron Bulls Are About To Meet Samsung's HBM4 Memory Chip (Rating Downgrade)
SummaryI am downgrading Micron Technology to hold ahead of the Q2 FY26 print.In my view, Samsung’s HBM4 production ramp poses a downside catalyst that could pressure MU’s market share and forward guidance even in a memory supply-constrained environment.After a 215% run since last summer, Micron now needs consistent beat-and-raise quarters. However, even this may not be enough given the current macro backdrop (remember NVDA last week).I see a strong memory cycle lasting into 2027. The top 8 CSPs are expected to spend over $710B in 2026 (up 61% yoy). Supply remains constrained.I see Q3 FY26 revenue guidance as the key bar. The Street expects $21.85B in revenue.JHVEPhoto/iStock Editorial via Getty Images
I am downgrading Micron Technology, Inc. (MU) to a hold heading into the Q2 FY26 print.
Aside from the current macro backdrop, which is no longer rewarding risk assets (particularly those in the tech sector, as shown in
11.45K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-03-06 07:105d ago
2026-03-06 00:005d ago
Archer-Daniels-Midland: Policy Wins Don't Fix This Dividend King's Valuation
Archer-Daniels-Midland remains a Hold, as current valuation lacks a margin of safety amid macro headwinds. ADM's adjusted FCF of ~$1.44 billion is underwhelming versus its $32.35 billion market cap given the industry they play in, with dividend growth outpacing fundamentals before and now slowing down. Cost savings of $500–$750 million over 3–5 years and diversification efforts are positive, but investment levels remain insufficient to support better returns.
2026-03-06 07:105d ago
2026-03-06 00:215d ago
EssilorLuxottica heir seeks multibillion deal to buy out siblings, FT says
Item 1 of 2 OneSight EssilorLuxottica Foundation's President Leonardo Maria Del Vecchio attends a conference in Rome, Italy October 5, 2023. REUTERS/Remo Casilli
[1/2]OneSight EssilorLuxottica Foundation's President Leonardo Maria Del Vecchio attends a conference in Rome, Italy October 5, 2023. REUTERS/Remo Casilli Purchase Licensing Rights, opens new tab
CompaniesMarch 6 (Reuters) - Leonardo Maria del Vecchio is nearing a deal to buy out two of his siblings from the family holding company Delfin, which controls EssilorLuxottica (ESLX.PA), opens new tab, the heir told the Financial Times in an interview published on Friday.
Get a daily digest of breaking business news straight to your inbox with the Reuters Business newsletter. Sign up here.
Reporting by Gursimran Kaur in Bengaluru; Editing by Mrigank Dhaniwala
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-03-06 07:105d ago
2026-03-06 00:405d ago
China approves Pfizer GLP-1 drug for weight management
A logo of Pfizer at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov/File Photo Purchase Licensing Rights, opens new tab
CompaniesSHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market analysts expect to be worth billions of dollars.
The injection belongs to the class of GLP-1 receptor agonist drugs sold locally by drugmakers such as Novo Nordisk (NOVOb.CO), opens new tab, Eli Lilly (LLY.N), opens new tab, and Innovent Biologics (1801.HK), opens new tab.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
"This marks a breakthrough in the field of weight management," Pfizer's licensing partner Sciwind Biosciences said on its website.
In February, Pfizer (PFE.N), opens new tab licensed the mainland China commercialisation rights for Xianweiying, also known as ecnoglutide, from Sciwind, based in the eastern city of Hangzhou.
That deal was "an important first step to advance Pfizer's global strategy in the metabolic field in China", Sciwind said in a previous statement.
Sales of Novo's Wegovy on Alibaba’s (9988.HK), opens new tab Tmall e-commerce platform and JD.com (9618.HK), opens new tab were 260 million yuan ($38 million) in 2025, against 416 million ($61 million) for Innovent's Xinermei, investment bank Jefferies said in a note.
The approval in China for long-term weight management props up Pfizer's footing in the booming weight-loss drug market.
It has also recently acquired the obesity drug developer Metsera, as well as another experimental GLP-1 drug from another developer.
A Pfizer spokesperson said in a statement to Reuters that Xianweiying was a once-a-week injection. They declined to comment about pricing and a China launch date.
Ecnoglutide is also approved in China as a treatment for Type 2I diabetes.
Reporting by Andrew Silver; Editing by Clarence Fernandez and Christian Schmollinger
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Nano Nuclear Energy (NNE 3.00%) shares went on a tear last fall, when small modular reactor (SMR) nuclear stocks were all the rage. More recently, however, price action has been far less exciting for this speculative growth stock.
During this time, Nano has traded sideways, even as the early-stage company has continued to report new developments. Yet while it is difficult to forecast when this stock could potentially become hot again, there is admittedly a factor at play that could serve as a double-edged sword for shares.
That would be Nano Nuclear Energy's high level of short interest. This factor could help the stock surge back above $50 per share on positive news, but could also send it back to new lows on bad news.
Today's Change
(
-3.00
%) $
-0.79
Current Price
$
25.57
With this in mind, now may not be the time to rush into a position.
Image source: Getty Images
Nano Nuclear Energy and its high short interest Short interest represents the percentage of shares sold short relative to a stock's outstanding share count, or float. Historically, short interest has served as a gauge of how much the market is betting against a particular stock.
More recently, however, with the emergence of the meme stock phenomenon, investors have also looked to high short interest as a bullish signal. In situations where a stock becomes heavily shorted, there is a chance of a short squeeze. That's when a stock quickly rises, typically on positive news, leading to short-sellers scrambling to cover positions.
In theory, a scenario like that could play out here with Nano. Short interest in Nano currently stands at around 25% of outstanding shares and 33% of outstanding float. It may only take a small amount of positive news, such as a well-received quarterly earnings report. Still, taking a closer look, it's tough to argue that a needle-moving development is just around the corner.
The big caveat, and why there's a better SMR wager out there Nano Nuclear Energy may have potential to squeeze, but don't assume another meme-fueled short squeeze is just around the corner. Digging further into the situation, there's much more out there suggesting the short side can "win" on this trade, at least in the short term.
Why? Even as Nano continues forming new partnerships to develop its microreactor technology, such as with the University of Illinois Urbana-Champaign and with South Korea's DS Dansuk, the company is expected to only start generating significant revenue several years from now.
Barring the announcement of a major commercial partnership, I don't see there being an upcoming event that kicks investor enthusiasm back into high gear. Over the longer term, as the monetization timeline remains long, Nano is at risk of burning through its $578 million cash position. This may lead to Nano needing to execute a dilutive capital raise, like it did last October.
Share dilution, or the prospect of it, is another factor that could put pressure on shares. Given these variables, if you're bullish on the SMR trend, you may want to consider other nuclear energy stocks. Nano's larger competitor, NuScale Power (SMR 2.87%) is a key example. Better capitalized and making greater monetization progress to boot, it may prove a more profitable way to play this energy technology trend.
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated November 25, 2025 to its short form base shelf prospectus dated October 31, 2025.
San Antonio, Texas--(Newsfile Corp. - March 6, 2026) - HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (BVC: HIVECO) (referred to as the "Company" or "HIVE"), a global leader in sustainable blockchain infrastructure, is pleased to announce that all resolutions considered at its 2025 annual general and special meeting of shareholders held on March 5, 2026 (the "Meeting") were approved by its shareholders.
Shareholders Approve Resolutions
The resolutions approved by the shareholders present in person or represented by proxy at the Meeting were:
All director nominees were duly re-elected to the Board. Accordingly, HIVE's Board remains comprised of Frank Holmes, Susan McGee, Marcus New and Dave Perrill. Each director will serve until HIVE's next annual meeting of shareholders or until their respective successors are elected or appointed or they otherwise cease to hold office.
Davidson & Company LLP was re-appointed as independent, external auditor of HIVE for the ensuing year or until its successor is appointed, and the Board was authorized to fix its remuneration.
The Company's amended incentive stock option plan was re-approved.
The Company's amended restricted share unit plan was re-approved.
The amendment of the Company's Articles to change the required quorum at a meeting of Shareholders to two (2) persons who are, or who represent by proxy, shareholders who, in the aggregate, hold at least 33 1∕3% of the issued common shares entitled to be voted at the meeting.
The resolutions voted on at the meeting are described in more detail in HIVE's Management Information Circular, dated January 16, 2026, which was mailed to shareholders and is available on the Company's SEDAR+ profile at www.sedarplus.ca.
About HIVE Digital Technologies Ltd.
Founded in 2017, HIVE Digital Technologies Ltd. is the first publicly listed company to mine digital assets powered by green energy. Today, HIVE builds and operates next-generation Tier-I and Tier-III data centers across Canada, Sweden, and Paraguay, serving both Bitcoin and high-performance computing clients. HIVE's twin-turbo engine infrastructure-driven by hashrate services and GPU-accelerated AI computing-delivers scalable, environmentally responsible solutions for the digital economy.
For more information, visit hivedigitaltech.com, or connect with us on:
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release
Forward-Looking Information
Except for the statements of historical fact, this news release contains "forward-looking information" within the meaning of the applicable Canadian and United States securities legislation and regulations that is based on expectations, estimates and projections as at the date of this news release. "Forward-looking information" in this news release includes but is not limited to: the results of the Company's annual general and special meeting of shareholders, business goals and objectives of the Company and other forward-looking information concerning the intentions, plans and future actions of the Company.
Factors that could cause actual results to differ materially from those described in such forward-looking information include, but are not limited to, the risks set out in the Company's disclosure documents under the Company's filings at www.sec.gov/EDGAR and www.sedarplus.ca.
The forward-looking information in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. In connection with the forward-looking information contained in this news release, the Company has made assumptions about the Company's objectives, goals or future plans, the timing thereof and related matters. The Company has also assumed that no significant events occur outside of the Company's normal course of business. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance, and accordingly, undue reliance should not be put on such information due to its inherent uncertainty. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286457
Source: HIVE Digital Technologies Ltd.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-03-06 07:105d ago
2026-03-06 01:005d ago
Hexagon Purus receive orders for delivery of hydrogen distribution units to a leading European energy company
March 06, 2026 01:00 ET | Source: Hexagon Purus ASA
(Oslo, 6 March 2026) Hexagon Purus, a world leading manufacturer of zero emission mobility and infrastructure solutions, has received purchase orders for the delivery of hydrogen distribution units from a leading Central European integrated energy company.
The total value of the order is approximately EUR 6.2 million and is scheduled for delivery in Q3 and Q4 2026.
“We are happy to welcome this new customer and to provide distribution units that will transport hydrogen to this leading European energy company’s growing mobility infrastructure network”, says Morten Holum, CEO of Hexagon Purus. “This order is a direct result of our recent efforts to diversify the customer base and contributes to strengthening our order book for the second half of 2026”.
Hexagon Purus enables zero emission mobility for a cleaner energy future. The company is a world leading provider of hydrogen Type 4 high-pressure cylinders and systems, battery systems and vehicle integration solutions for fuel cell electric and battery electric vehicles. Hexagon Purus' products are used in a variety of applications including light, medium and heavy-duty vehicles, buses, ground storage, distribution, refueling, maritime, rail and aerospace.
Learn more at www.hexagonpurus.com and follow @HexagonPurus on X and LinkedIn
2026-03-06 07:105d ago
2026-03-06 01:005d ago
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as the first targeted treatment for patients living with ocular MG Additional data from ADAPT SERON – the largest study of patients with gMG who do not have detectable AChR-Ab – demonstrate VYVGART’s efficacy and safety across subtypesNew biomarker analysis, real-world evidence and post-hoc insights highlight VYVGART’s expanding treatment approach in CIDP March 6, 2026, 7:00 AM CEST
Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, will present data for VYVGART® (IV: efgartigimod alfa-fcab and SC or Hytrulo: efgartigimod alfa and hyaluronidase-qvfc) and pipeline candidates empasiprubart and adimanebart at the 2026 American Academy of Neurology (AAN) Annual Meeting in Chicago from April 18-22, 2026.
“The data we will present at AAN, including new Phase 3 results in ocular myasthenia gravis, demonstrate our relentless efforts to deliver a targeted treatment option to as many patients living with MG as possible,” said Luc Truyen, M.D., Ph.D., Chief Medical Officer, argenx. “We are also advancing our pipeline across two new mechanisms of action, aiming to deliver precision therapies for several neurological diseases with high unmet need.”
Notable myasthenia gravis (MG) data supporting our pursuit of the broadest label for MG patients to be presented include:
Data from the Phase 3 ADAPT OCULUS study, the first registrational study specifically designed to evaluate a targeted therapy for ocular myasthenia gravis (oMG), confirm the therapeutic potential of VYVGART in adults with oMG, marking an important step forward to expand targeted treatment options for these patients.Data from Phase 3 ADAPT SERON and ADAPT Jr studies support the use of VYVGART across broader patient populations, including patients with generalized myasthenia gravis (gMG) who do not have detectable anti-acetylcholine receptor antibodies (AChR-Ab) across three subtypes – MuSK+, LRP4+, and triple seronegative gMG, as well as in adolescents with gMG.Additional MG presentations further characterize the long-term safety and efficacy of VYVGART across both trial and real-world settings, as well as sustained clinical benefit across dosing patterns. In chronic inflammatory demyelinating polyneuropathy (CIDP), argenx will highlight results from an ADHERE post hoc analysis in treatment-naïve patients that underscore VYVGART Hytrulo’s impact in this underserved population and support its use earlier in the treatment paradigm. Real-world insights will further illustrate physician approaches to transitioning patients from IVIg to VYVGART Hytrulo to support positive patient outcomes. Featured research also includes ADHERE neurofilament light chain (NfL) data from the most comprehensive dataset to date, advancing CIDP innovation by exploring this potential biomarker of disease.
Additional results from the ARGX-119 Phase 1b trial evaluating adimanebart in patients with DOK7 congenital myasthenic syndromes (CMS) will also be shared, providing proof-of-concept support based on a favorable safety profile and consistent functional improvements across multiple efficacy measures.
Details for oral and poster presentations at AAN are as follows:
TitleLead AuthorPresentationMyasthenia Gravis (MG)Efficacy and Safety of Efgartigimod in Anti-acetylcholine Receptor Antibody–Negative Generalized Myasthenia Gravis: Initial Results of ADAPT SERONJames F. Howard Jr.Oral Presentation #008
S14: Updates on Myasthenia Gravis
Monday, April 20
2:24 p.m. CTResults from the ADAPT JR Study Investigating Intravenous Efgartigimod in Juvenile Generalized Myasthenia GravisAbigail N. SchwaedeOral Presentation #002
S19: Emerging Therapies in Child Neurology
Monday, April 20
3:42 p.m. CTEfficacy and Safety of Subcutaneous Efgartigimod PH20 Administered by Prefilled Syringe in Adults With Ocular Myasthenia Gravis: Interim Results of ADAPT OCULUS Part AVern C. JuelPoster #022
P9: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Clinical Trials
Tuesday, April 21
5-6 p.m. CTSustained Clinical Efficacy and Long-term Safety of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXTArjun SethPoster #003
P9: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Clinical Trials
Tuesday, April 21
5-6 p.m. CTLong-term Safety and Efficacy of Subcutaneous Efgartigimod PH20 in Adult Participants With Generalized Myasthenia Gravis: Final Results of the ADAPT-SC+ StudyClaire Wan-Yi HuangPoster #002
P9: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Clinical Trials
Tuesday, April 21
5-6 p.m. CTDesign of a Phase 2a Study to Evaluate the Safety, Efficacy, and Tolerability of Intravenous Empasiprubart as an Add-On Therapy to Intravenous Efgartigimod in Adult Participants With Generalized Myasthenia GravisJeff GuptillPoster #021
P9: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Clinical Trials
Tuesday, April 21
5-6 p.m. CTSafety and Effectiveness of Efgartigimod in Japanese Patients With Generalized Myasthenia Gravis by Serological Profiles: Analysis of Post-marketing SurveillanceHirofumi TeranishiPoster #006
P9: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Clinical Trials
Tuesday, April 21
5-6 p.m. CTAssessing Efgartigimod Dosing Patterns and Myasthenia Gravis Activities of Daily Living Outcomes in Clinical Practice: Results From a Large Patient Support Program Database in the United StatesPushpa NarayanaswamiPoster #020
P11: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Treatments
Wednesday, April 22
11:45 a.m.-12:45 p.m. CTChronic Inflammatory Demyelinating Polyneuropathy (CIDP)Impact of Subcutaneous Efgartigimod PH20 on Treatment-naïve Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in the ADHERE Trial: Post Hoc AnalysesHans KatzbergPoster #002
P1: Neuromuscular and Clinical Neurophysiology (EMG): Autoimmune Neuropathies
Sunday, April 19
8-9 a.m. CTSerum NfL Z-score as a Biomarker of Disease Severity and Treatment History in the Largest CIDP Cohort to Date: Insights from the ADHERE TrialRoger Collet VidiellaPoster #004
P7: Neuromuscular and Clinical Neurophysiology (EMG): Peripheral Nerve Disorders
Tuesday, April 21
8-9 a.m. CTPhysician Insights on Transitioning Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy From Intravenous Immunoglobulin to Subcutaneous Efgartigimod PH20Jamie AldridgePoster #016
P7: Neuromuscular and Clinical Neurophysiology (EMG): Peripheral Nerve Disorders
8-9 a.m. CTCharacteristics of Real-world Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Initiating Subcutaneous Efgartigimod in United StatesNadia ZaveriPoster #013
P7: Neuromuscular and Clinical Neurophysiology (EMG): Peripheral Nerve Disorders
Tuesday, April 21
8-9 a.m. CTBeyond Disability: The Burden of Fatigue in CIDPSwapna KarkarePoster #007
P1: Neuromuscular and Clinical Neurophysiology (EMG): Autoimmune Neuropathies
Sunday, April 19
8-9 a.m. CTReal-world Effectiveness and Use of Efgartigimod in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: ADHERE REAL Study DesignChafic KaramPoster #011
P6: Neuromuscular and Clinical Neurophysiology (EMG): Peripheral Nerve and Other Neuromuscular Disorders
Monday, April 20
5-6 p.m. CTEmpasiprubart Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: EMNERGIZE Phase Three Study DesignThomas H. BrannaganPoster #021
P1: Neuromuscular and Clinical Neurophysiology (EMG): Autoimmune Neuropathies
Sunday, April 19
8-9 a.m. CTEmpasiprubart vs Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: EMVIGORATE Phase Three Study DesignSimon RinaldiPoster #022
P1: Neuromuscular and Clinical Neurophysiology (EMG): Autoimmune Neuropathies
Sunday, April 19
8-9 a.m. CTCongenital Myasthenic Syndromes (CMS)Phase 1b Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Efficacy of ARGX-119 in Participants with DOK7 Congenital Myasthenic SyndromesNancy L. KuntzOral Presentation #007
S32: General Neurology 1
Tuesday, April 21
4:42 p.m. CTMultiple Disease AreasEfgartigimod is a Unique FcRn Blocker That Allows IgG Reduction Without Broad Inhibition of Immune ResponsesKristin HeerleinPoster #008
P3: Autoimmune Neurology: Inflammatory NOS 1
Sunday, April 19
5-6 p.m. CT More information on the data presented at the 2026 AAN Annual Meeting can be found here.
Important Safety Information
What is VYVGART® (efgartigimod alfa-fcab)?
VYVGART is a prescription medicine used to treat a condition called generalized myasthenia gravis, which causes muscles to tire and weaken easily throughout the body, in adults who are positive for antibodies directed toward a protein called acetylcholine receptor (anti-AChR antibody positive).
IMPORTANT SAFETY INFORMATION
Do not use VYVGART if you have a serious allergy to efgartigimod alfa or any of the other ingredients in VYVGART. VYVGART can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
VYVGART may cause serious side effects, including:
Infection. VYVGART may increase the risk of infection. The most common infections were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain. Allergic Reactions (hypersensitivity reactions). VYVGART can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with VYVGART. Infusion-Related Reactions. VYVGART can cause infusion-related reactions. The most frequent symptoms and signs reported with VYVGART were high blood pressure, chills, shivering, and chest, abdominal, and back pain. Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.
Before taking VYVGART, tell your doctor if you:
take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have received or are scheduled to receive a vaccine (immunization), or have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding. What are the common side effects of VYVGART?
The most common side effects of VYVGART are respiratory tract infection, headache, and urinary tract infection.
These are not all the possible side effects of VYVGART. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.
Please see the full Prescribing Information for VYVGART and talk to your doctor.
Important Safety Information
What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?
VYVGART HYTRULO is a prescription medicine used to treat adults with:
generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.chronic inflammatory demyelinating polyneuropathy (CIDP). It is not known if VYVGART HYTRULO is safe and effective in children.
IMPORTANT SAFETY INFORMATION
Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:
have an infection or fever.have recently received or are scheduled to receive any vaccinations.have any history of allergic reactions.have kidney (renal) problems.are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby. Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
VYVGART HYTRULO can cause side effects which can be serious, including:
Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection: fever, chills, frequent and painful urination, cough, pain and blockage or nasal passages, wheezing, shortness of breath, sore throat, excess phlegm, nasal discharge.Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction: rash, swelling of the face, lips, throat, or tongue, shortness of breath, hives, trouble breathing, low blood pressure, fainting.Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction: high blood pressure, chills, shivering, chest, stomach, or back pain. The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.
These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see the full Prescribing Information for VYVGART HYTRULO and talk to your doctor.
About VYVGART and VYVGART Hytrulo
VYVGART® (efgartigimod alfa fcab) is a first-in-class human IgG1 antibody fragment that binds to the neonatal Fc receptor (FcRn), resulting in the reduction of circulating IgG autoantibodies. VYVGART® Hytrulo is a subcutaneous combination of efgartigimod alfa (VYVGART) and recombinant human hyaluronidase PH20 (rHuPH20), Halozyme’s ENHANZE® drug delivery technology to facilitate subcutaneous injection delivery of biologics. VYVGART is approved for generalized myasthenia gravis (gMG) and immune thrombocytopenia (Japan only). VYVGART Hytrulo is approved for gMG and chronic inflammatory demyelinating polyneuropathy (CIDP). VYVGART Hytrulo may be marketed under different proprietary names in other regions.
About Empasiprubart
Empasiprubart (ARGX-117) is a novel humanized monoclonal antibody that binds C2 and blocks activation of both the classical and lectin pathways of the complement cascade. By blocking complement activity upstream of C3 and C5, empasiprubart has the potential to reduce tissue inflammation and cellular damage, representing a broad pipeline opportunity across multiple severe autoimmune indications. In addition to multifocal motor neuropathy, argenx is evaluating empasiprubart in delayed graft function following kidney transplant, and chronic inflammatory demyelinating polyneuropathy (CIDP).
About Adimanebart
Adimanebart (ARGX-119) is a first-in-class humanized agonist monoclonal antibody (mAb) that specifically targets and activates muscle-specific tyrosine kinase (MuSK) to promote maturation and stabilization of the neuromuscular junction (NMJ). It is a mAb derived from llamas and discovered using the argenx SIMPLE Antibody™ platform technology. Adimanebart is being developed for patients with neuromuscular disease, including congenital myasthenic syndromes (CMS), amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). Adimanebart was developed through argenx’s IIP program in collaboration with the world’s leading key opinion leaders on MuSK and the NMJ, Professor Steven J. Burden from MGH, Professor Shohei Koide from NYU and Professor Jan Verschuuren and Associate Professor Maartje Huijbers from LUMC.
About Generalized Myasthenia Gravis (gMG)
Generalized myasthenia gravis (gMG) is a rare and chronic autoimmune disease where IgG autoantibodies disrupt communication between nerves and muscles, causing debilitating and potentially life-threatening muscle weakness. Approximately 85% of people with MG progress to gMG within 24 months, where muscles throughout the body may be affected. Patients with confirmed AChR antibodies account for approximately 85% of the total gMG population.
About Ocular Myasthenia Gravis (oMG)
Ocular myasthenia gravis (oMG) is a rare and chronic autoimmune disease characterized by muscle weakness limited to the muscles controlling the eyes and eyelids. Symptoms commonly include ptosis (drooping eyelids), diplopia (double vision), and fluctuating visual disturbance that can impair daily activities. Approximately 80% of myasthenia gravis (MG) patients initially present with ocular symptoms, and up to 92% experience ocular involvement at some point during the course of disease. While many progress to generalized myasthenia gravis (gMG), in 15–25% of patients, weakness remains restricted to the ocular muscles. oMG is driven by pathogenic IgG autoantibodies that disrupt communication at the neuromuscular junction. Despite the functional and quality-of-life burden associated with persistent ocular symptoms, there are currently no approved targeted therapies specifically for oMG. Treatment approaches often rely on symptomatic therapies and generalized immunosuppression, underscoring the need for additional therapeutic options for this distinct MG population.
About Generalized Myasthenia Gravis (gMG) without detectable AChR-Ab
Generalized myasthenia gravis (gMG) is a rare, chronic, neuromuscular autoimmune disease caused by pathogenic IgGs targeting the neuromuscular junction (NMJ), resulting in impaired neuromuscular transmission and debilitating and potentially life-threatening muscle weakness and chronic fatigue. Approximately 80% of patients with gMG have detectable antibodies against the AChR in sera, and these patients are diagnosed as AChR-Ab seropositive gMG. Approximately 20% of patients with gMG do not have detectable serum antibodies directed against AChR. These patients may have detectable autoantibodies targeting other NMJ proteins, such as muscle-specific tyrosine kinase (MuSK) and low-density lipoprotein receptor-related protein 4 (LRP4), or others. Anti-MuSK antibodies are detected in approximately 1-10% of patients with gMG, while anti-LRP4 antibodies are detected in approximately 1-5% of patients with gMG. About 10% of patients do not have any detectable autoantibodies against AChR, MuSK or LRP4. These triple seronegative patients have historically been excluded from studies and have a higher disease burden and unmet medical need compared to patients with detectable autoantibodies. Currently, there are no approved treatments available for patients with anti-LRP4 antibodies or for triple seronegative patients.
About Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare and serious autoimmune disease of the peripheral nervous system. CIDP is a heterogenous disease involving different yet overlapping pathways and a varied disease course. There is increasing evidence that IgG antibodies and the complement system play a key role in the damage to the peripheral nerves. People with CIDP experience fatigue, muscle weakness and a loss of feeling in their arms and legs that can worsen over time or may come and go. These symptoms can significantly impair a person's ability to function in their daily lives. Without treatment, one-third of people living with CIDP will need a wheelchair.
About Congenital Myasthenic Syndromes (CMS)
Congenital Myasthenic Syndromes (CMS) are an ultra-rare and heterogenous group of congenital neuromuscular disorders caused by genetic defects that are essential for the integrity of the neuromuscular junction. Early age of onset and fatigable muscle weakness are considered clinical hallmarks of CMS. Muscle weakness can be debilitating and life-threatening causing difficulties in speaking or swallowing, impaired or absent mobility, proximal arm and leg weakness, and respiratory insufficiency. DOK7 variations are one of the more frequent and severe causes of CMS, accounting for approximately 24% of CMS cases. There are no approved treatments. The prevalence of CMS is estimated to be 5 per 1M (DOK7-CMS estimated to be 1.2 per 1M).
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, Instagram, Facebook, and YouTube.
The contents of this announcement include statements that are, or may be deemed to be, “forward-looking statements.” These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “advance,” “aim,” “build,” “commit,” “continue,” “potential,” and “will,” and include statements argenx makes concerning its plan to present certain new data at 2026 AAN Annual Meeting (including data for VYVGART and pipeline candidates empasiprubart and adimanebart) that continue to transform patient outcomes in myasthenia gravis (MG) and chronic inflammatory demyelinating polyneuropathy (CIDP) and build upon strength of pipeline; VYVGART’s potential as the first targeted treatment for patients living with ocular MG; VYVGART’s expanding treatment approach in CIDP; its advancement of its pipeline across two new mechanisms of action with an aim to deliver precision therapies for several neurological diseases with high unmet need; its plan to present myasthenia gravis (MG) data supporting its pursuit of the broadest label for MG patients, including: (1) data from the Phase 3 ADAPT OCULUS study, demonstrating the therapeutic potential of VYVGART in adults with oMG and the potential expansion of targeted treatment options for these patients, marking an important step forward to expand targeted treatment options for these patients; (2) data from Phase 3 ADAPT SERON and ADAPT Jr studies, supporting the use of VYVGART across broader patient populations, including patients with generalized myasthenia gravis (gMG) who do not have detectable anti-acetylcholine receptor antibodies (AChR-Ab) across three subtypes – MuSK+, LRP4+, and triple seronegative gMG, as well as in adolescents with gMG; and (3) additional MG presentations further characterizing the long-term safety and efficacy of VYVGART across both trial and real-world settings, as well as sustained clinical benefit across dosing patterns; its plan to highlight results from an ADHERE post hoc analysis in treatment-naïve patients with chronic inflammatory demyelinating polyneuropathy (CIDP) that underscore VYVGART Hytrulo's impact in this underserved population and support its use earlier in the treatment paradigm; its intent to use real-world insights to further illustrate physician approaches to transitioning patients from IVIg to VYVGART Hytrulo to support positive patient outcomes; its plan to present featured research which includes ADHERE neurofilament light chain (NfL) data from the most comprehensive dataset to date, advancing CIDP innovation by exploring this potential biomarker of disease; its plan to share additional results from the ARGX-119 Phase 1b trial evaluating adimanebart in patients with DOK7 congenital myasthenic syndromes (CMS), providing proof-of-concept support based on a favorable safety profile and consistent functional improvements across multiple efficacy measures; argenx’s relentless efforts to deliver a targeted treatment option to as many patients living with MG as possible; its commitment to improve the lives of people suffering from severe autoimmune diseases; its aim to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines; its commercialization of the first approved neonatal Fc receptor (FcRn) blocker and evaluation of its broad potential in multiple serious autoimmune diseases; and its advancement of several earlier stage experimental medicines within its therapeutic franchises. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. argenx’s actual results may differ materially from those predicted by the forward-looking statements as a result of various important factors, including but not limited to, the results of argenx’s clinical trials; expectations regarding the inherent uncertainties associated with the development of novel drug therapies; preclinical and clinical trial and product development activities and regulatory approval requirements; the acceptance of its products and product candidates by its patients as safe, effective and cost-effective; the impact of governmental laws and regulations, including tariffs, export controls, sanctions and other regulations on its business; its reliance on third-party suppliers, service providers and manufacturers; inflation and deflation and the corresponding fluctuations in interest rates; and regional instability and conflicts. A further list and description of these risks, uncertainties and other risks can be found in argenx’s U.S. Securities and Exchange Commission (SEC) filings and reports, including in argenx’s most recent annual report on Form 20-F filed with the SEC as well as subsequent filings and reports filed by argenx with the SEC. Given these uncertainties, the reader is advised not to place any undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date of publication of this document. argenx undertakes no obligation to publicly update or revise the information in this press release, including any forward-looking statements, except as may be required by law.
2026-03-06 07:105d ago
2026-03-06 01:055d ago
The Cooper Companies, Inc. (COO) Q1 2026 Earnings Call Transcript
BOCA RATON, Fla., March 06, 2026 (GLOBE NEWSWIRE) -- REalloys Inc. (NASDAQ: ALOY) (the “Company” or “REalloys”), a U.S.-based mine-to-magnet rare earth company, today announced the pricing of its previously announced underwritten public offering of 2,702,702 shares of its common stock at a public offering price of $18.50 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 396,963 shares of common stock. The offering is expected to close on or about March 9, 2026, subject to the satisfaction of customary closing conditions.
Clear Street is acting as lead book-running manager for the offering.
Needham & Company is acting as joint book-running manager for the offering.
Laidlaw & Company (UK) Ltd. and Muriel Siebert & Co. are acting as co-managers for the offering.
Cantor is acting as capital markets advisor to the Company in connection with the Offering.
The gross proceeds from the offering to the Company are expected to be approximately $50 million, before deducting underwriting discounts and other offering expenses and excluding any exercise of the underwriters’ option to purchase additional shares. The Company expects to use the net proceeds of the offering for working capital and general corporate purposes.
The securities described above are being offered by the Company pursuant to a shelf registration statement on Form S-3 (File No. 333-284626) previously filed with the Securities and Exchange Commission (“SEC”) and declared effective by the SEC on February 10, 2025. The offering will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective shelf registration statement. A preliminary prospectus supplement relating to and describing the terms of the offering was filed on March 5, 2026. A final prospectus supplement and accompanying prospectus relating to the securities being offered will be filed with the SEC. Copies of the preliminary prospectus supplement and accompanying prospectus may be obtained, when available, for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, you may contact Clear Street, Attn: Syndicate Department, 150 Greenwich Street, 45th floor, New York, NY 10007, by email at [email protected], or Needham & Company, 250 Park Avenue, 10th Floor, New York, NY 10177, Attn: Prospectus Department, [email protected], or by telephone at (800) 903-3268.
This press release shall not constitute an offer to sell or the solicitation of any offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
About REalloys:
REalloys Inc. is advancing a fully integrated North American mine-to-magnet supply chain encompassing upstream resource development, midstream processing, and downstream manufacturing. REalloys' upstream foundation includes its Hoidas Lake rare-earth asset in Saskatchewan and a diversified network of allied feedstock and recycling partners. Together with the Saskatchewan Research Council, REalloys is building a platform to scale North American heavy rare earth midstream separation, refining, and metallization capabilities—creating a coordinated system that processes and converts heavy rare-earth materials from allied and domestic sources into high-purity products. Those refined materials feed directly into REalloys’ downstream manufacturing operations in Euclid, Ohio, where the company produces advanced heavy rare earth metals, alloys and magnet components for defense, clean-energy, and high-performance industrial applications. REalloys’ Ohio facility serves federal logistics and procurement agencies supporting the Department of Defense, the Department of Energy, and National Aeronautics and Space Administration, in addition to the broader Defense Industrial Base and Organic Industrial Base.
For more information, go to www.realloys.com or email [email protected]
Forward Looking Statements and Safe Harbor
This press release contains “forward-looking statements” within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including, without limitation, statements regarding the satisfaction of the closing conditions, prevailing market conditions, statements regarding the satisfaction of the closing conditions, the anticipated use of the proceeds of the offering which could change as a result of market conditions or for other reasons, development activities, market expansion, strategic initiatives, or future performance are forward-looking statements. Such statements reflect management’s current expectations, assumptions, and estimates and are inherently subject to significant risks and uncertainties, many of which are beyond the control of the Company. Words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “target,” “will,” and similar expressions are intended to identify forward-looking statements, though their absence does not mean a statement is not forward-looking.
These statements are not guarantees of performance or outcomes. Actual results may differ materially from those expressed or implied due to various factors, including but not limited to: the ability to successfully complete project development and commercialization efforts; uncertainties related to scaling new technologies or processes to industrial production; supply-chain reliability, logistics, and availability of equipment and materials; fluctuations in rare-earth prices or demand; changes in market conditions, customer preferences, or procurement policies; regulatory approvals, environmental compliance, and permitting delays; inflationary pressures or rising capital costs; the availability, cost, and terms of financing; geopolitical events and trade policies affecting critical minerals; the outcome of future collaborations or partnerships; workforce recruitment and retention; cybersecurity or intellectual-property risks; competitive developments or technological change; and macroeconomic or industry-specific conditions that could impact operations, markets, or valuations.
All forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements to reflect subsequent events, new information, or changes in expectations, except as required by law. Readers are cautioned not to place undue reliance on these statements, which are provided for the purpose of describing management's current expectations and strategic outlook, and which involve numerous known and unknown risks, uncertainties, and other factors that may cause actual results or performance to differ materially.
These statements should not be construed as forecasts or guarantees of future outcomes. The risks and uncertainties that could affect the Company's operations, financial condition, performance, and prospects include those described in its filings with the SEC, including the most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other periodic reports and filings with the SEC available at www.sec.gov.
Contacts
REalloys Inc.
Angela Gorman
Communications, REalloys [email protected]
www.realloys.com
2026-03-06 07:105d ago
2026-03-06 01:165d ago
Profound Medical Corp. (PRN:CA) Q4 2025 Earnings Call Transcript
Q4: 2026-03-05 Earnings SummaryEPS of $0.16 beats by $0.13
|
Revenue of
$75.85M
beats by $6.15M
Omada Health, Inc. (OMDA) Q4 2025 Earnings Call March 5, 2026 4:30 PM EST
Company Participants
Allan Kells - Vice President of Investor Relations
Sean Duffy - Co-Founder, CEO & Director
Wei-Li Shao - President
Steven Cook - Chief Financial Officer
Conference Call Participants
David Roman - Goldman Sachs Group, Inc., Research Division
Sean Dodge - BMO Capital Markets Equity Research
Craig Hettenbach - Morgan Stanley, Research Division
Ryan MacDonald - Needham & Company, LLC, Research Division
Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division
Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division
Richard Close - Canaccord Genuity Corp., Research Division
Carly Buecker - Barclays Bank PLC, Research Division
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Omada Health Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions]
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Allan Kells, Vice President, Investor Relations. Please go ahead.
Allan Kells
Vice President of Investor Relations
Thank you. Good afternoon. Welcome to Omada Health's Fourth Quarter and Full Year 2025 Earnings Call. Joining me today are Sean Duffy, our Co-Founder and CEO; Wei-Li Shao, President; and Steve Cook, our CFO.
Before we begin, I'd like to note that we'll be discussing non-GAAP financial measures that we consider helpful in evaluating Omada's performance. You can find details on how these relate to our GAAP measures along with the reconciliations in the press release available on our website.
We'll also be making forward-looking statements based on our current expectations and assumptions, which are subject to risks and uncertainties including factors listed in our press release and in the risk factors found in our filings with the SEC. Actual results could differ materially, and we assume no obligation to update these forward-looking statements. With that, I'll turn the call over
2026-03-06 07:105d ago
2026-03-06 01:195d ago
REalloys Announces Pricing of Upsized $50 Million Public Offering
BOCA RATON, Fla., March 6, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – REalloys Inc. (NASDAQ: ALOY) (the “Company” or “REalloys”), a U.S.-based mine-to-magnet rare earth company, today announced the pricing of its previously announced underwritten public offering of 2,702,702 shares of its common stock at a public offering price of $18.50 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 396,963 shares of common stock. The offering is expected to close on or about March 9, 2026, subject to the satisfaction of customary closing conditions.
Clear Street is acting as lead book-running manager for the offering.
Needham & Company is acting as joint book-running manager for the offering.
Laidlaw & Company (UK) Ltd. and Muriel Siebert & Co. are acting as co-managers for the offering.
Cantor is acting as capital markets advisor to the Company in connection with the Offering
The gross proceeds from the offering to the Company are expected to be approximately $50 million, before deducting underwriting discounts and other offering expenses and excluding any exercise of the underwriters’ option to purchase additional shares. The Company expects to use the net proceeds of the offering for working capital and general corporate purposes.
The securities described above are being offered by the Company pursuant to a shelf registration statement on Form S-3 (File No. 333-284626) previously filed with the Securities and Exchange Commission (“SEC”) and declared effective by the SEC on February 10, 2025. The offering will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective shelf registration statement. A preliminary prospectus supplement relating to and describing the terms of the offering was filed on March 5, 2026. A final prospectus supplement and accompanying prospectus relating to the securities being offered will be filed with the SEC. Copies of the preliminary prospectus supplement and accompanying prospectus may be obtained, when available, for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, you may contact Clear Street, Attn: Syndicate Department, 150 Greenwich Street, 45th floor, New York, NY 10007, by email at [email protected], or Needham & Company, 250 Park Avenue, 10th Floor, New York, NY 10177, Attn: Prospectus Department, [email protected], or by telephone at (800) 903-3268.
This press release shall not constitute an offer to sell or the solicitation of any offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
About REalloys:
REalloys Inc. is advancing a fully integrated North American mine-to-magnet supply chain encompassing upstream resource development, midstream processing, and downstream manufacturing. REalloys’ upstream foundation includes its Hoidas Lake rare-earth asset in Saskatchewan and a diversified network of allied feedstock and recycling partners. Together with the Saskatchewan Research Council, REalloys is building a platform to scale North American heavy rare earth midstream separation, refining, and metallization capabilities—creating a coordinated system that processes and converts heavy rare-earth materials from allied and domestic sources into high-purity products. Those refined materials feed directly into REalloys’ downstream manufacturing operations in Euclid, Ohio, where the company produces advanced heavy rare earth metals, alloys and magnet components for defense, clean-energy, and high-performance industrial applications. REalloys’ Ohio facility serves federal logistics and procurement agencies supporting the Department of Defense, the Department of Energy, and National Aeronautics and Space Administration, in addition to the broader Defense Industrial Base and Organic Industrial Base.
For more information, go to www.realloys.com or email [email protected]
Forward Looking Statements and Safe Harbor
This press release contains “forward-looking statements” within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact, including, without limitation, statements regarding the satisfaction of the closing conditions, prevailing market conditions, statements regarding the satisfaction of the closing conditions, the anticipated use of the proceeds of the offering which could change as a result of market conditions or for other reasons, development activities, market expansion, strategic initiatives, or future performance are forward-looking statements. Such statements reflect management’s current expectations, assumptions, and estimates and are inherently subject to significant risks and uncertainties, many of which are beyond the control of the Company. Words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “target,” “will,” and similar expressions are intended to identify forward-looking statements, though their absence does not mean a statement is not forward-looking.
These statements are not guarantees of performance or outcomes. Actual results may differ materially from those expressed or implied due to various factors, including but not limited to: the ability to successfully complete project development and commercialization efforts; uncertainties related to scaling new technologies or processes to industrial production; supply-chain reliability, logistics, and availability of equipment and materials; fluctuations in rare-earth prices or demand; changes in market conditions, customer preferences, or procurement policies; regulatory approvals, environmental compliance, and permitting delays; inflationary pressures or rising capital costs; the availability, cost, and terms of financing; geopolitical events and trade policies affecting critical minerals; the outcome of future collaborations or partnerships; workforce recruitment and retention; cybersecurity or intellectual-property risks; competitive developments or technological change; and macroeconomic or industry-specific conditions that could impact operations, markets, or valuations.
All forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements to reflect subsequent events, new information, or changes in expectations, except as required by law. Readers are cautioned not to place undue reliance on these statements, which are provided for the purpose of describing management’s current expectations and strategic outlook, and which involve numerous known and unknown risks, uncertainties, and other factors that may cause actual results or performance to differ materially.
These statements should not be construed as forecasts or guarantees of future outcomes. The risks and uncertainties that could affect the Company’s operations, financial condition, performance, and prospects include those described in its filings with the SEC, including the most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other periodic reports and filings with the SEC available at www.sec.gov.
Contacts
REalloys Inc.
Angela Gorman
Communications, REalloys [email protected]
www.realloys.com
Source: REalloys Inc.
PMW on Newsramp: https://newsramp.com/newswire/prism
Add us on Google as a Preferred Source to see more News in your Search Results
2026-03-06 07:105d ago
2026-03-06 01:245d ago
Varonis Systems, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VRNS
, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Varonis Systems, Inc. ("Varonis " or "the Company") (NASDAQ: VRNS ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of VRNS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: February 4, 2025 and October 28, 2025
DEADLINE: March 9, 2026
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Varonis was struggling to convert clients to its SaaS platform, but continued to share exceedingly positive statements about its performance with investors. Based on these facts, Varonis' public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate .
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]
SOURCE DJS Law Group LLP
2026-03-06 07:105d ago
2026-03-06 01:255d ago
Maple Leaf Foods Inc. (MFI:CA) Q4 2025 Earnings Call Transcript
Q4: 2026-03-05 Earnings SummaryEPS of $0.32 beats by $0.06
|
Revenue of
$991.24M
(-19.87% Y/Y)
beats by $4.49M
Maple Leaf Foods Inc. (MFI:CA) Q4 2025 Earnings Call March 5, 2026 8:00 AM EST
Company Participants
Omar Javed - Vice President of Investor Relations
Curtis Frank - President, CEO & Director
David Smales - Chief Financial Officer
Conference Call Participants
Luke Hannan - Canaccord Genuity Corp., Research Division
Irene Nattel - RBC Capital Markets, Research Division
John Zamparo - Scotiabank Global Banking and Markets, Research Division
Mark Petrie - CIBC Capital Markets, Research Division
Vishal Shreedhar - National Bank Financial, Inc., Research Division
Etienne Ricard - BMO Capital Markets Equity Research
Michael Van Aelst - TD Cowen, Research Division
Presentation
Operator
Good morning, everyone. Welcome to Maple Leaf Foods Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] I would now like to turn the conference over to Omar Javed, Vice President of Investor Relations at Maple Leaf Foods. Please go ahead, Mr. Javed.
Omar Javed
Vice President of Investor Relations
Thank you, and good morning, everyone. Before we begin, I would like to remind you that statements made on today's call may constitute forward-looking information, and our future results may differ materially from what we discuss. Please refer to our fourth quarter and full year 2025 MD&A and financial statements and other information on our website for a broader description of operations and risk factors that could affect the company's performance.
We've also uploaded our fourth quarter and full year 2025 investor presentation to our website. As always, the Investor Relations team will be available after the call for any follow-up questions you may have.
With that, I'll turn the call over to our President and CEO, Curtis Frank.
Curtis Frank
President, CEO & Director
Okay. Thank you, Omar, and good morning, everyone. Thank you for being with us here on our call today. Joining me this morning is our Chief Financial Officer, David Smales. After my opening remarks, Dave
2026-03-06 07:105d ago
2026-03-06 01:285d ago
CoreWeave, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CRWV
, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against CoreWeave, Inc. ("CoreWeave " or "the Company") (NASDAQ: CRWV ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of CRWV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: March 28, 2025 to December 15, 2025
DEADLINE: March 13, 2026
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. CoreWeave understated the risk of relying on a single third-party provider for data centers while also overplaying its ability to meet customer demand. Based on these facts, CoreWeave's public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate .
WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]
SOURCE DJS Law Group LLP
2026-03-06 07:105d ago
2026-03-06 01:325d ago
Full Year 2025 Results: Atos Group has Delivered on its Commitments to Restore its Foundations. Growth Chapter Ready to be Opened.
Full Year 2025 Results:
Atos Group has Delivered on its Commitments to Restore its Foundations
Growth Chapter Ready to be Opened
FY 2025 financial and extra financial targets met or exceeded: Revenue at €8,001 million, reflecting a clear improvement in the organic growth trajectory in Q4Operating margin at €351 million, representing 4.4% of revenue, doubling year-on-yearNet change in cash1 limited to €-326 million despite faster than expected execution of the restructuring programGreenhouse gas emissions reduced by 58% compared with the 2019 baseline. Execution of Genesis strategic and transformation plan ahead of schedule, with 88%2 of the three-year savings target completed in less than one yearStrengthened commercial traction, with early signs of renewed client confidenceScaling artificial intelligence (AI) from targeted solutions to a fully integrated agentic AI-powered operating model across the Group, supported by Atos Sovereign Agentic Studios in France, Germany, the U.K. and the U.S.Confirmed promising outlook with positive cash generation from 2026 and accelerating in 2027 and 2028Solid capital structure to secure long-term ambition Strong liquidity position and long-term debt maturityAtos SE equity restored into positive territory Paris, March 6th, 2025 - Atos, a leading provider of AI-powered digital transformation, today announces its full year 2025 financial results.
Philippe Salle, Atos Group Chairman of the Board of Directors and Chief Executive Officer, stated:
“The year 2025 marked a decisive turning point for our Group, confirming the relevance of the discipline, strategic clarity and transformation initiated under the Genesis plan. We met or exceeded our financial targets, improving the Group’s profitability and cash generation. We restored our operational foundations with a more resilient, and performance-driven operating model. Major commercial wins, industry recognition and strong market positions reflect renewed and growing client confidence across our businesses.
In a world being rapidly reshaped by AI acceleration, cybersecurity imperatives, and digital sovereignty, we have a unique business opportunity. We are stepping forward to expand our role as a trusted mission-critical technology partner. Our AI-first operating model powered by four newly launched agentic studios, the rapid ramp-up of our Data & AI workforce and the launch of our new consulting brand, positions us to support clients in adopting AI at scale, securely and responsibly. As we enter 2026, Atos Group is fundamentally transformed: more focused, more competitive and more agile. A new chapter of AI‑led growth is now opening and we are ready. The future doesn’t wait... neither do we.”
FY 2025 performance highlights
In € millionFY 2025FY 2024Var. FY 2024*Organic Var.Revenue8,0019,577-1,575 9,284-1,282Operating Margin351199+152 172+179In % of revenue4.4%2.1%+2.3 bps 1.9%-2.5 bpsOMDA883722+160 In % of revenue11.0%7.5%+3.5 bps Net income – Group share-1,404248-1,652 Net change in cash3-326-735+409 Net debt (excl. IFRS 9 adjustment)-1,844-1,238-606 *: at constant scope and December 2025 average exchange rates
Operational performance
On a full-year basis, Group revenue reached €8,001 million - or €8,030 million at September 30 currency - in line with the previously communicated target of “above €8 billion4”. Atos SBU generated revenue of €6,963 million, down -16.2% organically compared to FY 2024. The Eviden SBU revenue was up +6.7% compared to FY 2024, to €1,039 million in FY 2025.
Group operating margin reached €351 million in FY 2025 - or 4.4% of revenue (compared to 1.9% in FY 2024), above the previously communicated target of “around €340 million or above 4%”. This represents 104% organic growth year-on-year, despite a €1,282 million organic revenue decline. This performance demonstrates the benefits of the cost reduction measures implemented since the beginning of the year under the Genesis transformation plan.
In € million FY 2025 RevenueFY 2024* RevenueOrganic variationFY 2025 OMFY 2024 OM*FY 2025 OM (%)Organic variation* Atos6,9638,310-16.2%4033055.8%+98 Germany, Austria & Central Europe1,5041,665-9.7%26-161.7%+42 North America1,2661,756-27.9%13515410.7%-19 France1,1401,271-10.3%28232.5%+5 UK & Ireland1,1281,465-23.0%82837.2%-1 International Markets1,1121,312-15.2%90458.1%+44 BNN (Belux, Netherlands, Nordics)801830-3.5%5566.9%+49 Global Delivery Centers11109.9%-149-0.2%-22 Eviden1,0399746.7%48-424.6%+89 Global Structures000.0%-100-91-1.2%-8 Group total8,0019,284-13.8%3511724.4%+179 *: at constant scope and December 2025 average exchange rates
Atos – Germany, Austria & Central Europe revenue totaled €1,504 million in FY 25, representing a -9.7% organic decline compared to FY 2024, with a few large client-ramp downs following insourcing strategies. It also stemmed from managed exits from low-profitability contracts. That was partially offset by successful fertilization, cross-selling to existing clients and the acquisition of new clients.
Operating margin improved by 269 basis points (bps) year-on-year, driven by the restructured delivery of the existing contract portfolio and benefits from Genesis-driven cost-cutting initiatives.
Atos – North America revenue was €1,266 million in FY 2025, representing a -27.9% organic decline compared to FY 2024. This decrease was mostly driven by 2024 contract exit decisions related to the Group’s financial situation before successful financial restructuring, as well as a net scope reduction among existing clients. The business has not yet benefited from improving commercial momentum, although signs of recovery are emerging with growing order entry and some ramp-ups.
Operating margin improved by 193 bps compared to FY 2024 despite the material impact from revenue fall through, driven by the Genesis-led margin optimization actions already in place.
Atos – France revenue reached €1,140 million in FY 2025, down -10.3% organically from FY 2024, due to high exposure to a recently muted public sector market that led to a significant ramp down, as well as the impact of the financial restructuring process on client perception in 2024.
Operating margin improved by 65 bps year-on-year despite declining revenues driven by the benefit of cost-cutting initiatives on indirect costs, an improved billability rate.
Atos – UK & Ireland revenue reached €1,128 million in FY 2025, down -23.0% organically year-on-year, mainly due to planned completion of large public sector Business Process Outsourcing (BPO) contracts in the fourth quarter of 2024. Subsequently, the fourth quarter has seen a return to organic growth (+2.5% yoy) supported by increased adoption of offerings among existing clients (notably with government clients), and new accretive revenue from new clients, especially in the financial services sector.
Operating margin improved by 159 bps compared to FY 2024. In absolute terms, it was stable year-on-year despite the sharp decrease in revenue due to the restructuring of low profitability contracts, successful delivery of new business and an already visible impact from cost-saving initiatives.
Atos – International Markets revenue was down -15.2% organically in FY 2025, to €1,112 million, mostly driven by softer performance in Asia Pacific, Switzerland and major events that benefited from the Olympics in fiscal year 2024.
Operating margin improved by 460 bps compared to FY 2024, doubling year-on-year in absolute terms. The contribution from lost revenue was more than offset by improved productivity, benefits from the Genesis transformation plan and lower one-off costs year-on-year with Olympics-related marketing costs incurred in fiscal year 2024.
Atos – BNN (Belux, Netherlands & Nordics) revenue stood at €801 million in FY 2025, down -3.5% organically compared to FY 2024, with churn partially offset by growing activity at existing clients.
Operating margin improved by 612 bps compared to FY 2024, to 6.9% in FY 2025, driven by the ramp down of lower profitability contracts, productivity improvement and positive impact from cost reduction initiatives.
Eviden revenue was €1,039 million in FY 2025, up 6.7% year-on-year, driven by the strong performance of the Advanced Computing activity with the delivery of the Jupiter supercomputer in the third quarter.
As a result, operating margin improved by 887 bps, reaching €48 million.
Global Structures costs stood at €-100 million in FY 2025, compared to -91 million euros in FY 2024 at constant scope and December 2025 average exchange rates.
Order Entry and Backlog
Commercial activity
In 2025, the Group carried out a comprehensive reset of its commercial organization to improve efficiency, increase accountability, and strengthen go-to-market performance. First benefits were already visible, particularly in productivity and pipeline quality.
Order entry reached €7,084 million in FY 2025, bringing the book-to-bill ratio to 89% vs 82% restated last year and indicating early signs of renewed client confidence. Main contract signatures in 2025 included:
A Cybersecurity contract with the EU CommissionA Digital Workplace contract with the UK Department for Environment, Food & Rural Affairs (Defra) A Cloud & Modern Infrastructure contract with a leading insurance company in North AmericaThe application of the extension of the customer relationship agreement with Siemens in Germany. Renewal rate reached 92% in FY 2025, compared to 89% in FY 2024.
Backlog and commercial pipeline
At the end of December 2025, the full backlog reached €10.7 billion, representing 1.3 years of revenue. The full qualified pipeline amounted to €4.2 billion at the end of December 2025, representing 6.2 months of revenue and showing a year-on-year increase in key business lines, such as Digital Applications and Data & AI.
Update on the Genesis plan Execution
At the Capital Markets Day held on May 14, 2025, the Group unveiled “Genesis”, its strategic and transformation plan for the next four years. It includes 22 workstreams regrouped under seven pillars:
GrowthHuman ResourcesCountries reviewPortfolio reviewGross MarginCost reviewCash During 2025 significant progress was achieved with 88%5 of the three-year savings target completed with initiatives implemented during the year, including the following:
Countries review: To sharpen the geographical focus, the Group exited or terminated commercial operations in ten countries and disposal processes led or will lead to the exit of seven moreContract portfolio review: The Group reduced its exposure to low margin contracts (i.e., contracts with a project margin below 5%) to c.€16 million negative impact on operating margin compared to c. €122 million in 2024.Delivery and general and administrative (G&A) optimization: The billability rate improved from 76% to 79% and the G&A cost base was reduced by 26% compared to 2024. Overall, over three quarters of the three-year restructuring envelope of 700 million euros was incurred during the year. The total headcount was 63,193 at the end of the period. ESG Performance in 2025 and Beyond
Atos Group has delivered on the promise it made in 2019 and has achieved its near-term Science Based Targets initiative (SBTi) objective to reduce its 2025 emissions by 50% compared to 2019. Furthermore, the Group reaffirmed its commitment during its Capital Markets Day in May 2025, to further reduce its GHG emissions to be net-zero by 2050 compared to 2025 and as defined by the SBTi. Atos Group will continue to mobilize its resources to decrease GHG emissions in its own operations and its supply chain, as well as to develop solutions and services to support its clients’ decarbonization ambitions.
Atos Group set a target to reach 40% female representation among new hires by the end of 2025. While significant progress was made and the target was not fully achieved, the Group continues to strengthen its initiatives to improve gender balance.
Atos Group also recognizes its responsibility to support and actively shape the transformation towards artificial intelligence and has therefore developed a training program. In 2025, 73% of the Group had completed the AI Fluency program, a strong indicator of our workforce readiness for AI-driven transformation.
Atos Group’s ambitions for sustainable digital business are reflected in very good assessment results. The Group is proud to be included for the 13th consecutive year in the S&P Global Sustainability Yearbook, reaffirming the company’s longstanding commitment to responsible business practices and leadership in environmental, social and governance (ESG) performance. Atos Group’s most recent Corporate Sustainability Assessment (CSA) score is 73/100, positioning the Group among the strongest performers worldwide across ESG dimensions within its industry.
In 2025, the company was included in CDP’s Climate “B List”, demonstrating performance above the global average in the management of climate related risks, governance, and strategic climate action. This result confirms the credibility and structure of Atos’ climate strategy.
Furthermore, Atos Group has once again been awarded EcoVadis Platinum Medal for its Corporate Social Responsibility (CSR) performance, with an improved score of 84 out of 100. This recognition places the Group in the top 1% of companies assessed by EcoVadis in its industry.
Acceleration of the Group’s Technological Ambition
Atos Group’s positioning in mission-critical, regulated, complex IT environments makes AI a structural opportunity for the Group. Rather than displacing core services, AI increases complexity, security requirements, compliance burdens, and integration demand — all areas where the group is deeply embedded.
The Group’s defensive characteristics — long-term client relationship, complex project management, cybersecurity expertise, and sovereign positioning — create resilience against AI disruption risk while offering upside through automation and higher-value AI-powered services.
Atos Group’s transformation is built on three mutually reinforcing tech‑strategic pillars — Agentic AI, Digital Sovereignty and Cybersecurity. Atos enters the AI‑first era with strong differentiators: deep partnerships, enterprise‑scale AI operations, mission‑critical expertise and secure‑by‑design delivery, enabling clients to move beyond proofs of concept and deploy AI in regulated, brownfield and operationally critical environments. AI becomes truly transformative when embedded into sovereign architectures and protected by advanced cyber capabilities, creating a self‑reinforcing flywheel where sovereignty ensures trust, cybersecurity ensures resilience and AI accelerates value creation.
In particular, Eviden – Atos Group branch providing security, cybersecurity and defense products and systems delivers deterministic, safety critical solutions — built on decades of expert data and robust command and control platforms, which remain unmatched for reliability. GenAI and agentic AI act as force multipliers, not replacements, expanding Eviden’s market through natural language control for non‑experts, context aware intelligence that enhances situational awareness, and optimized AI models deployable at the edge. With strong credentials in sovereignty and compliance, Eviden is positioned to provide safer, more resilient, and more predictive critical systems while remaining a trusted integrator for uptime, safety, and regulatory assurance.
Since 2025, Atos Group operationalized this strategy by appointing a new CTO, creating a dedicated Data & AI business line, developing workforce skills and launching a full portfolio redesign built around agentic AI, digital sovereignty and cybersecurity. It is now further accelerating industrialization through the launch of Atos Sovereign Agentic Studios in the U.S., the UK, France and Germany, enabling safe, governed, production‑grade AI agents embedded directly into clients’ operations and designed to scale autonomous execution, secure orchestration and software‑driven delivery for mission‑critical environments.
Atos Group also launched Atos Amplify, a unified AI‑powered consulting business unit designed to accelerate client transformation by combining deep industry expertise, advanced technology capabilities, and a strong focus on AI, cybersecurity and digital sovereignty. With a proven track record across major European and global clients, Atos Amplify brings an AI‑ready consult‑to‑build model that delivers tangible business outcomes, integrating Atos’ people, processes and assets with responsible AI guardrails to ensure secure, tailored and high‑impact transformation at scale.
Together, these moves position Atos to accelerate its development in the AI era with a robust, sovereign and secure foundation.
Human Resources
The total headcount was 63,193 at the end of December 2025, a decrease of -19.1% compared with the end of December 2024 essentially as a result of the execution of the Genesis headcount reduction program.
During the year, the Group hired 6,041 staff (of which 92.4% were direct employees), while attrition rate in FY 2025 was at 15.3% vs 15.6% in 2024.
Net income
Other Operating Income (OOI)
Other operating income and expenses amounted to €–1,179 million for full-year 2025, compared to –€2,858 million for full-year 2024. It mostly included restructuring and other non-recurring charges in relation to the Genesis transformation plan, as well as litigation and some onerous contracts provisions and asset impairment in the context of the disposal of Advanced Computing activities.
Financial income
Net financial expense was €-437 million for full-year 2025, compared to €3,121 million for full-year 2024, reflecting the new debt structure of the Group and the fair value adjustment of the net debt.
Tax
Tax charge stood at €-139 million for full-year 2025, compared to €-214 million for full-year 2024. It included a net change in deferred tax assets of €-60 million.
Net result Group share
As a result of the above net result Group share was a loss of €–1,404 million for full-year 2025, compared to a win of €248 million for full-year 2024.
Net Change in Cash6
Net change in cash6 for the period stood at €-326 million euros for the period, in line with the previously communicated target of “better than €-350 million”, and reflecting the following items:
Operating margin before depreciation and amortization (OMDA) of €883 millionCapex of €-170 million, or 2.1% of revenuesLeases paid for €-278 millionChange in working capital requirement (excluding WCA) of €33 million, mostly driven by lower activity in 2025Cash restructuring of €-445 million, mostly in relation to the Genesis transformation planTax paid of €-31 millionNet cash cost of debt of €–160 million, including €34 million of financial incomeOther items for €–157 million, which included litigation and onerous contracts Net Debt and Debt Covenants
At December 31, 2025, net debt was €1,843 million (€945 million including IFRS 9 debt fair value adjustment), compared to €1,238 million as of December 31, 2024 (€275 million including IFRS 9 debt fair value adjustment), and mainly consisted of:
Cash and cash equivalents for €1,265 millionBorrowings for €3,064 million (nominal value, excluding PIK) or €2,285 million including IFRS 9 fair value adjustment and PIK. The Group is considering the possibility of repurchasing bond debt on the market. It will evaluate any such transaction in the future in light of existing market conditions. The credit documentation requires the Group to maintain:
A minimum liquidity level of €650 million, to be verified at the end of each financial quarter starting March 31, 2025.A maximum level of financial leverage (“Total Net Leverage Ratio Covenant”), applicable from 30 June 2027, as from each half-year end, which is defined as the ratio of financial indebtedness (mainly excluding IFRS 16 impacts and IFRS 9 debt fair value treatment) to pre-IFRS 16 OMDA; the ceilings thus applicable will be determined no later than 30 June 2026 with reference to a flexibility of 30% in relation to the Business Plan adopted by the Group at that time; these ceilings will in any event remain between 3.5x and 4.0x As of December 31, 2025, the Group’s financial leverage ratio (as defined in the glossary) was 3.17x.
Outlook
Following the disposal of Advanced Computing activities, the Ideal GRP subsidiary in the Nordics and the Atos operations in South America, the Group’s baseline for establishing future ambition represented revenues and operating margin of €7,187 million and €314 million respectively7 in FY 2025.
From this baseline, in 2026, the Group anticipates a year of stabilization and aims to deliver:
positive organic growth, with a downside scenario limited to –5% in a challenging market environmentan operating margin of around 7%positive net change in cash8 before debt repayment, M&A and at constant currency. The Group foresees an acceleration of profitable growth and cash generation to accelerate in 2027 and in 2028. Assuming the disposal of Advanced Computing in FY 2026 and a progressive reduction of its geographic footprint, the Group expects:
To generate organic revenue CAGR of 5 to 7% between 2026 and 2028. Strategic, targeted and disciplined M&A could further increase revenue over the period To reach an operating margin of around 10% in FY 2028, supported by cost reduction measures and profitable growth, partially offset by an acceleration of R&D investments To achieve a leverage ratio below 1.5x net debt/OMDAL9 in fiscal year 2028. On the path to an investment grade rating, the Group expects to achieve a BB profile in 2027. Consolidated Financial Statements
Atos Group’s Board of Directors in its meeting held on March 5, 2026, reviewed the Group consolidated financial statements as of December 31, 2025. Audit procedures on the consolidated financial statements have been carried out and the audit report is being issued.
Conference Call
Atos Group’s management will host a conference call on Friday, March 6, 2026 at 8:00 am (Paris - CET)
You can join the webcast of the conference via the following link:
https://edge.media-server.com/mmc/p/usqbqtex If you want to join the conference by telephone, please register via this link:
https://register-conf.media-server.com/register/BI0336bca1fb00469289a4f64698fcaf37 Upon registration, you will receive the dial-in info and a unique PIN to join the conference call as well as an email confirmation with the details.
After the conference, a replay of the webcast will be available on our website, in the Investors section.
In € million Q4 2025 RevenueQ4 2024* RevenueOrganic variation Atos1,7381,910-9.0% Germany, Austria & Central Europe378414-8.7% North America272358-23.9% France285309-7.9% UK & Ireland3032952.5% International Markets299330-9.3% BNN (Belux, Netherlands, Nordics)198201-1.9% Global Delivery Centers42n.s. Eviden265299-11.2% Global Structures000.0% Group total2,0042,209-9.3% *: at constant scope and December 2025 average exchange rates
FY 2024 revenue and operating margin at constant scope and exchange rates reconciliation
For the analysis of the Group’s performance, revenue and operating margin (OM) for FY 2025 are compared with FY 2024 revenue and OM at constant scope and foreign exchange rates. Reconciliation between the FY 2024 reported revenue and OM, and the FY 2024 revenue and OM at constant scope and foreign exchange rates is presented below, by Strategic Business Unit (SBU) and by geography for the Atos SBU.
FY 2024 revenueFY 2024 publishedRestatementFY 2024 restatedInternal transfersScope effectsExchange rates effectsFY 2024*In € millionAtos8,1524508,602-5-148-1408,310Germany, Austria & Central Europe1,5651191,6840-2111,665North America1,759711,83000-741,756France1,301741,375-6-9801,271UK & Ireland1,446351,48100-161,465International Markets1,342501,3930-29-511,312BNN (Belux, Netherlands, Nordics)73297828101830Global Delivery Centers731100-110Eviden1,424-45097450-5974Global Structures0000000Group Total9,57709,5770-148-1449,284 *: at constant scope and December 2025 average exchange rates
FY 2024 Operating Margin FY 2024 publishedRestatementFY 2024 restatedInternal transfersScope effectsExchange rates effectsFY 2024*In € millionAtos312-53087-199305Germany, Austria & Central Europe-242-22-2-412-16North America168-116710-14154France25-4207-11723UK & Ireland83183-10083International Markets48249-2-5245BNN (Belux, Netherlands, Nordics)247-4046Global Delivery Centers11-8380-29Eviden-225-18-73-19-42Global Structures-910-91000-91Group Total19901990-17-10172 *: at constant scope and December 2025 average exchange rates
Restatement corresponds to the transfer of Cybersecurity Services from Eviden to Atos.
Scope effects on revenue amounted to €-148 million and €-17 million on operating margin. They are mainly related to the divestiture of Worldgrid in France, International Markets (Iberia) and Germany.
Currency effects contributed negatively to revenue for €-144 million and €-10 million on operating margin. They mostly came from the depreciation of the US dollar, the British pound, the Brazilian real, the Argentinian peso and the Turkish lira.
Q4 2024 revenue at constant scope and exchange rates reconciliation
For the analysis of the Group’s performance, revenue for Q4 2025 is compared with Q4 2024 revenue at constant scope and foreign exchange rates.
Q4 2024 revenueQ4 2024 publishedRestatementQ4 2024 restatedInternal transfersScope effectsExchange rates effectsQ4 2024*In € million Atos1,9001072,007-1-25-721,910Germany, Austria & Central Europe388294170-41414North America3751639200-34358France30817325-1-150309UK & Ireland305931400-19295International Markets344123560-6-20330BNN (Belux, Netherlands, Nordics)17823201000201Global Delivery Centers2120002Eviden408-10730210-3299Global Structures0000000Group Total2,30902,3090-25-752,209 * at constant scope and December 2025 average exchange rates
H2 2024 Operating margin at constant scope and exchange rates reconciliation
For the analysis of the Group’s performance, the operating margin for ssH2 2025 is compared with H2 2024 operating margin at constant scope and foreign exchange rates.
H2 2024 operating margin H2 2024 publishedRestatementH2 2024 restatedInternal transfersScope effectsExchange rates effectsH2 2024*In € million Atos137-21355-4-3133Germany, Austria & Central Europe-80-80-25-5North America72-17110-1061France11-1940215UK & Ireland3603600-135International Markets819-1-107BNN (Belux, Netherlands, Nordics)7070018Global Delivery Centers13-21120-113Eviden-62-4-53-6-12Global Structures-470-47000-47Group Total840840-1-874 * at constant scope and December 2025 average exchange rates
FY 2025 revenue after Advanced Computing activities,
South America operations and Ideal divestitures
(preliminary estimations of the impact of divestitures,
segment split subject to further internal transfers)
FY 2025 revenue
FY 2025
publishedDivestituresFY 2025
after divestituresIn € million Atos6,963-1366,827Germany, Austria & Central Europe1,50401,504North America1,26601,266France1,14001,140UK & Ireland1,12801,128International Markets1,112-121991BNN (Belux, Netherlands, Nordics)801-15787Global Delivery Centers11011Eviden1,039-718320Global Structures04040Group Total8,001-8147,187 FY 2025 revenue
FY 2025
publishedDivestituresFY 2025
after divestituresIn € million Financial Services & Insurance18%220%Public Sector & Defense34%-331%Health & Life Sciences8%19%Manufacturing18%018%Resources & Services12%013%Telecom, Media & Technology9%09%Other--1%Group Total100%0100% FY 2025 operating margin after Advanced Computing activities,
South America Operations and Ideal’s Divestitures
(preliminary estimations of the impact of divestitures,
segment split subject to further internal transfers)
FY 2025 operating margin
FY 2025
publishedDivestituresFY 2025
after divestituresIn € million Atos403-9393Germany, Austria & Central Europe26026North America1350135France28028UK & Ireland82082International Markets90-882BNN (Belux, Netherlands, Nordics)55-253Global Delivery Centers-140-14Eviden48-3513Global Structures-1008-92Group Total351-37314 In accordance with IFRS 5, the Group determined that the asset group related to the contemplated disposal of “Advanced Computing” activities met the criteria to be classified as assets held for sale, given the advanced stage of negotiations with the French State and the expected completion of the transaction during the first half of 2026.
Furthermore, these activities held for sale were not classified as discontinued operations in the income statement within the meaning of IFRS 5, as they do not represent a major and separate line of business for the Group.
FY 2025 consolidated Profit & Loss Account
(in € million)December 31, 2025December 31,2024Revenue 8,0019,577Personnel expense-3,974-4,966Non-personnel operating expense-3,677-4,412Operating margin351199% of revenue4.4%2.1%Other operating income and expense-1,179-2,858Operating income (loss)-828-2,659% of revenue-10.4%-27.8%Net cost of financial debt-333-178Other financial expense-136-423Other financial income343,722Net financial income (expense)-4363,121Net income (loss) before tax-1,264462Tax charge-139-214Share of net profit (loss) of equity-accounted investments 0Net income (loss)-1,404248Of which: ▪ attributable to owners of the parent-1,404248▪ non-controlling interests10 FY 2025 Consolidated Cash Flow Statement
in € million12 months ended December 31, 202512 months ended
December 31, 2024 Net income (loss) before tax -1,264462 Depreciation of fixed assets251254 Depreciation of right-of-use193257 Net addition (release) to operating provisions-537 Net addition (release) to financial provisions54-11 Net addition (release) to other operating provisions219206 Amortization of intangible assets (PPA from acquisitions)2657 Impairment of goodwill and other non-current assets1662,384 Losses (gains) on disposals of non-current assets180-109 Net charge for equity-based compensation114 Unrealized losses (gains) on changes in fair value and other-0- Net cost of financial debt333178 Interests on lease liability2935 Other non cash refinancing items2-3,666 Net cash from (used in) operating activities
before change in working capital requirement and taxes14858 Tax paid-31-81 Change in working capital requirement122-1,379 Net cash from (used in) operating activities239-1,402 Payment for tangible and intangible assets-170-444 Proceeds from disposals of tangible and intangible assets34 Net operating investments-167-440 Outflows related to financial assets-18- Inflows related to financial assets8276 Cash and cash equivalents of companies sold during the period--39 Net long-term financial investments-10237 Net cash from (used in) investing activities-177-203 Common stock issued2145 Purchase and sale of treasury stock--2 Dividends paid--13 Dividends paid to non-controlling interests-3-5 Amounts paid for acquisition of non-controlling interests-- Lease payments-278-301 New borrowings-2,150 Repayment of borrowings-4-725 Interests paid-160-178 Other flows related to financing activities--51 Net cash from (used in) financing activities-4421,019 Increase (decrease) in net cash and cash equivalents-380-586 Opening net cash and cash equivalents1,7392,295 Increase (decrease) in net cash and cash equivalents-380-586 Impact of exchange rate fluctuations on cash and cash equivalents-9429 Closing net cash and cash equivalents1,2651,739 December 31, 2025December 31, 2024In € million Cash and cash equivalents before IFRS5
Cash and cash equivalents relating to IFRS51,265
-191,739
-Cash and cash equivalents after IFRS51,2451,739 FY 2025 Balance Sheet
(in € million)December 31,
2025December 31, 2024ASSETS Goodwill465653Intangible assets247349Tangible assets240580Right-of-use assets308550Equity-accounted investments1112Non-current financial assets91131Deferred tax assets124184Total non-current assets1,4862,458Trade accounts and notes receivable1,7692,435Current taxes60102Other current assets1,0231,510Current financial instruments02Cash and cash equivalents1,2451,739Total current assets4,0985,788Assets held for sale7390TOTAL ASSETS6,3228,246(in € million)December 31,
2025December 31, 2024LIABILITIES AND SHAREHOLDERS’ EQUITY Common stock1918Additional paid-in capital1,8871,887Consolidated retained earnings-1,290-1,354Net income (loss) attributable to the owners of the parent-1,404248Equity attributable to the owners of the parent-787799Non-controlling interests-30Total shareholders’ equity-790799Provisions for pensions and similar benefits597782Non-current provisions358345Borrowings2,2632,089Deferred tax liabilities3369Non-current lease liabilities315498Other non-current liabilities43Total non-current liabilities3,5713,787Trade accounts and notes payable8751,018Current taxes10175Current provisions373315Current financial instruments00Current portion of borrowings2217Current lease liabilities162207Other current liabilities1,5502,028Total current liabilities3,0833,660Liabilities held for sale4580TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY6,3228,246 Glossary
Operational capital employed: Operational capital employed comprises net fixed assets and net working capital but excludes goodwill and net assets held for sale.
Current and non-current assets or liabilities: A current and non-current distinction is made between assets and liabilities on the consolidated statement of financial position. Atos has classified as current assets and liabilities those assets and liabilities that Atos expects to realize, use or settle during its normal cycle of operations, which can extend beyond 12 months following the period end. Current assets and liabilities, excluding the current portion of borrowings, lease liabilities and provisions, and current financial instruments represent the Group’s working capital requirement.
DSO: (Days of Sales Outstanding). DSO is the amount of trade accounts receivable (including contract assets) expressed in days of revenue (on a last-in, first-out basis). The number of days is calculated in accordance with the Gregorian calendar.
Organic growth: Organic growth represents the percent growth of a unit based on a constant scope and exchange rates basis.
CAGR: The Compound Annual Growth Rate reflects the mean annual growth rate over a specified period of time longer than one year. It is calculated by dividing the value at the end of the period in question by its value at the beginning of that period, raise the result to the power of one divided by the period length, and subtract one from the subsequent result. As an example:
Operating margin: Operating margin equals to External Revenues less personnel and operating expense. It is calculated before Other operating income and expense as defined below.
Other operating income and expense:
Other operating income and expense include:
The amortization and impairment of intangible assets recognized as part of business combinations such as customer relationships, technologies and goodwillWhen accounting for business combinations, the Group may record provisions in the opening statement of financial position for a period of 12 months beyond the business combination date. After the 12-month period, unused provisions arising from changes in circumstances are released through the income statement under “Other operating income and expense”the cost of acquiring and integrating newly controlled entities, including earn out with or without presence conditionsthe net gains or losses on disposals of consolidated companies or businessesthe fair value of shares granted to employees including social contributionsthe restructuring and rationalization expense relating to business combinations or qualified as unusual, infrequent and abnormal. When a restructuring plan qualifies for Other operating income and expense, the related real estate rationalization & associated costs regarding premises are presented on the same linethe curtailment effects on restructuring costs and the effects of plan amendments on defined benefit plans resulting from triggering events that are not under control of Atos managementthe net gain or loss on tangible and intangible assets that are not part of Atos core-business such as real estateother unusual, abnormal and infrequent income or expense such as major disputes or litigation. Gross margin and indirect costs: Gross margin is composed of revenue less the direct costs of goods sold. Direct costs relate to the generation of products and/or services delivered to customers, while indirect costs include all costs related to indirect staff (defined hereafter), which are not directly linked to the realization of the revenue. The operating margin comprises gross margin less indirect costs.
EBITDA (Earnings Before Interest, Tax, Depreciation and Amortization): For Atos, EBITDA is based on Operating Margin less non-cash items and is referred to as OMDA (Operating Margin before Depreciation and Amortization).
OMDA (Operating Margin before Depreciation and Amortization) is calculated as follows:
Operating margin, plus:
Depreciation of fixed assets (as disclosed in the “financial report”);Depreciation of right of use (as disclosed in the “financial report”);Net book value of assets sold/written of (as disclosed in the "financial report");Net charge (release) of provisions (composed of net charge of provisions for current assets and net charge of provisions for contingencies and losses, both disclosed in the “financial report”);Net charge (release) of provisions for pensions (as disclosed in the “financial report”). OMDAL: OMDA – lease repayments.
Gearing: The proportion, expressed as a percentage of net debt to total shareholders’ equity (Group share and minority interests).
Interest cover ratio: Operating margin divided by the net cost of financial debt, expressed as a multiple.
Leverage ratio: Net debt (before IFRS 9 fair value adjustment) / OMDAL last 12-months
Operating income (loss): Operating income (loss) comprises net income (loss) before deferred and current income taxes, net financial income (expense), and share of net profit (loss) of equity-accounted investments.
Cash flow from operations: Cash flow coming from the operations and calculated as a difference between OMDA, net capital expenditures, lease payment and change in working capital requirement.
Net cash or net debt: Net cash or net debt comprises total borrowings (bonds, short-term and long-term loans, securitization and other borrowings), short-term financial assets and liabilities bearing interest with maturity of less than 12 months, less cash and cash equivalents. Liabilities associated with lease contracts and derivatives are excluded from the net debt.
Free Cash Flow (FCF): The Free Cash Flow represents the change in net cash or net debt, excluding capital increase, share buyback, dividends paid to shareholders and non-controlling interests, net acquisition or disposal of companies.
Earnings (loss) per share (EPS): Basic EPS is the net income (loss) divided by the weighted-average number of common shares outstanding during the period. Diluted EPS is the net income (loss) divided by the diluted weighted-average number of common shares for the period (number of shares outstanding plus dilutive instruments with dilutive effect).
Revenue: Revenue related to Atos’ sales to third parties (excluding VAT).
TCV (Total Contract Value): The Total Value of a Contract at signature (prevision or estimation) over its duration represents the firm order and contractual part of the contract excluding any clause on the decision of the client, as anticipated withdrawal clause, additional option or renewal.
Order entry/bookings: The TCV, orders or amendments signed during a defined period. When an offer is won (contract signed), the total contract value is added to the backlog and the order entry is recognized.
Book-to-bill: The Book-to-Bill is the ratio expressed in percentage of the order entry in a period divided by revenue of the same period.
Backlog/Order cover: The value of signed contracts, orders and amendments that remain to be recognized over their contract lives. It may include revenue recognized on contracts based on the actual use of billable services such as volume-based considerations. It does not hence represent the transaction price allocated to performance obligations not yet satisfied (backlog) as defined by IFRS 15.
Pipeline: The value of revenues that may be earned from outstanding commercial proposals issued to clients. A qualified pipeline applies an estimated percentage likelihood of proposal success.
Direct Staff: Direct staff includes permanent staff and subcontractors, whose work is billable to a third party.
Indirect staff: Indirect staff includes permanent staff or subcontractors, who are not billable to clients. Indirect staff are not directly involved in the generation of products and/or services delivered to clients.
Disclaimer
This document contains forward-looking statements that involve risks and uncertainties, including references, concerning the Group’s expected growth and profitability in the future which may significantly impact the expected performance indicated in the forward-looking statements. These risks and uncertainties are linked to factors out of the control of the Company and not precisely estimated, such as market conditions or competitors’ behaviors. Any forward-looking statements made in this document are statements about Atos’s beliefs and expectations and should be evaluated as such. Forward-looking statements include statements that may relate to Atos’s plans, objectives, strategies, goals, future events, future revenues or synergies, or performance, and other information that is not historical information. Actual events or results may differ from those described in this document due to a number of risks and uncertainties that are described within the 2024 Universal Registration Document filed with the Autorité des Marchés Financiers (AMF) on April 10, 2025 under the registration number D.25-0238. Atos does not undertake, and specifically disclaims, any obligation or responsibility to update or amend any of the information above except as otherwise required by law.
This document does not contain or constitute an offer of Atos’s shares for sale or an invitation or inducement to invest in Atos’s shares in France, the United States of America or any other jurisdiction. This document includes information on specific transactions that shall be considered as projects only. In particular, any decision relating to the information or projects mentioned in this document and their terms and conditions will only be made after the ongoing in-depth analysis considering tax, legal, operational, finance, HR and all other relevant aspects have been completed and will be subject to general market conditions and other customary conditions, including governance bodies and shareholders’ approval as well as appropriate processes with the relevant employee representative bodies in accordance with applicable laws.
About Atos Group
Atos Group is a global leader in digital transformation with c. 63,000 employees and annual revenue of c. € 8 billion, operating in 61 countries under two brands — Atos for services and Eviden for products. European number one in cybersecurity, cloud and high-performance computing, Atos Group is committed to a secure and decarbonized future and provides tailored AI-powered, end-to-end solutions for all industries. Atos Group is the brand under which Atos SE (Societas Europaea) operates. Atos SE listed on Euronext Paris.
The purpose of Atos Group is to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the Group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space.
1 Net change in cash before debt repayment, and calculated before the estimated impacts of i/ exchange rate fluctuation, ii/ M&A and iii/ change in unsolicited payments received in advance of the invoice payment due date during the year
2 Including 2025 in-year savings and carry-over savings to materialize in 2026
3 Net change in cash before debt repayment, and calculated before the estimated impacts of i/ exchange rate fluctuation, ii/ M&A and iii/ change in unsolicited payments received in advance of the invoice payment due date during the year
4 At September 30, 2025 currency
5 including 2025 in-year savings and carry-over savings to materialise in 2026
6 Net change in cash before debt repayment, and calculated before the estimated impacts of i/ exchange rate fluctuation, ii/ M&A and iii/ change in unsolicited payments received in advance of the invoice payment due date during the year
7 Preliminary estimations, see more details in appendix
8 Net change in cash before debt repayment, and calculated before the estimated impacts of i/ exchange rate fluctuation, ii/ M&A and iii/ change in unsolicited payments received in advance of the invoice payment due date during the year
9 Defined as Operating Margin before Depreciations, Amortization and Leases
10 Covers Data & AI external revenues explicitly identified within the scope of the new business line implemented in July 2025, excluding Data & AI services embedded in offerings of other business lines. Total external revenue for Data & AI activities estimated at above 2%. Covers Digital Transformation consulting external revenues explicitly identified within the scope of the entity, excluding consulting services embedded in offerings of other business lines.
PR - Atos Group - FY 25 Results
2026-03-06 07:105d ago
2026-03-06 01:335d ago
Atos hits yearly revenue target after restructuring slashed 19% of workforce
The logo of French IT consulting firm Atos is seen during the 107th session of the Congress of Mayors organised by the "France's Mayors' Association" (AMF) at the Paris Expo Porte de... Purchase Licensing Rights, opens new tab Read more
March 6 (Reuters) - French IT services company Atos (ATOS.PA), opens new tab reported full-year revenue slightly above 8 billion euros ($9.3 billion) on Friday, meeting its target and reflecting progress in its turnaround following significant financial restructuring.
The company slashed its headcount by 19% to 63,193 employees as part of its "Genesis" restructuring programme aimed at restoring profitability after years of turmoil.
Get a daily digest of breaking business news straight to your inbox with the Reuters Business newsletter. Sign up here.
Revenue in the core Atos business unit declined 16.2% organically to 6.96 billion euros despite winning a notable cybersecurity contract with the European Commission during the year.
Sales in the Eviden division grew 6.7% to 1.04 billion euros, driven by the delivery of the Jupiter supercomputer in Germany.
Atos had a backlog of 10.7 billion euros at the end of December, representing 1.3 years of revenue, signalling a solid pipeline of contracted work that underpins its confidence in the recovery path.
Atos expects 2026 to be a "year of stabilization" with a target of positive organic revenue growth, and potential downside limited to a 5% decline in a challenging market.
It expects to accelerate growth in 2027-2028, aiming for 5-7% annual revenue growth and a 10% operating margin by 2028.
Atos also aims to reduce its leverage ratio to net debt less than 1.5 times its operating income by 2028, as it pursues an investment-grade credit rating.
($1 = 0.8610 euros)
Reporting by Leo Marchandon in Gdansk, editing by Milla Nissi-Prussak
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-03-06 07:105d ago
2026-03-06 01:385d ago
Deutsche Lufthansa Posts In-Line Earnings On Lower Costs, Increased Passengers
Universal Music Group N.V. (UNVGY) Q4 2025 Earnings Call March 5, 2026 12:15 PM EST
Company Participants
Lucian Grainge - Chairman & CEO
Michael Nash - Executive VP & Chief Digital Officer
Matthew Ellis - Chief Financial Officer
Boyd Muir - Executive VP & COO
Conference Call Participants
Omar Mejias Santiago - Wells Fargo Securities, LLC, Research Division
James Heaney - Jefferies LLC, Research Division
Julien Roch - Barclays Bank PLC, Research Division
Peter Supino - Wolfe Research, LLC
Clayton Griffin - MoffettNathanson LLC
Michael Morris - Guggenheim Securities, LLC, Research Division
Silvia Cuneo - Deutsche Bank AG, Research Division
Presentation
Operator
Good evening, and welcome to Universal Music Group's Fourth Quarter and Full Year Earnings Call for the period ended December 31, 2025.
My name is Nadia, and I'll be your conference operator today. Your speakers for today's call will be Sir Lucian Grainge, Chairman and CEO of Universal Music Group; Michael Nash, Chief Digital Officer; and Matt Ellis, Chief Financial Officer. They will be joined during Q&A by Boyd Muir, Chief Operating Officer.
[Operator Instructions] As a reminder, this call is being recorded.
Please also let me remind you that management's commentary and responses to questions on today's call may include forward-looking statements, which, by their nature, are uncertain and outside of the company's control. Although these forward-looking statements are based on management's current expectations and beliefs, actual results may vary in a material way. For a discussion of some of the factors that could cause actual results to differ from expected results, please see the Risk Factors section of UMG's 2024 annual report, which is available on the Investor Relations page of UMG's website at universalmusic.com. Management's commentary will also refer to non-IFRS measures on today's call. Reconciliations are available in the press release on the Investor Relations page of UMG's website. Thank you.
2026-03-06 07:105d ago
2026-03-06 01:495d ago
Ingram Micro Holding Corporation Announces Pricing of Secondary Offering of Common Stock by its Principal Stockholder.
IRVINE, Calif.--(BUSINESS WIRE)--Ingram Micro Holding Corporation (the “Company”) announced today the pricing of the previously announced secondary public offering of 8,988,764 shares of the Company's common stock (“Common Stock,” and such offering, the “Offering”), at a price to the public of $22.25 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) by Ingram Holdco, LLC, an affiliate of Platinum Equity, LLC (the “Selling Stockho.
2026-03-06 07:105d ago
2026-03-06 02:025d ago
InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 06
LONDON, UK / ACCESS Newswire / March 6, 2026 / The Company announces that on 05 March 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.
Date of purchase:
05 March 2026
Aggregate number of ordinary shares purchased:
20,000
Lowest price paid per share:
$ 131.6500
Highest price paid per share:
$ 135.1500
Average price paid per share:
$ 133.6046
The Company intends to cancel the purchased shares.
Following the above transaction, the Company has 150,700,048 ordinary shares in issue (excluding 5,481,782 held in treasury).
A full breakdown of the individual purchases by GSI is included below.
Investor Relations: Stuart Ford (+44 (0)7823 828 739); Kate Carpenter (+44 (0) 7825 655 702); Joe Simpson (+44 (0)7976 862 072)
Media Relations: Neil Maidment (+44 (0)7970 668 250); Mike Ward (+44 (0)7795 257 407)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
I have maintained a "Buy" rating for Techtronic Industries despite the FY25 miss; there were non-recurring items that weighed on its results. TTNDY is guiding for a mid-to-high single-digit revenue growth in FY26, supported by favorable business mix shifts and international expansion. Future profitability improvement is underpinned by a greater emphasis on higher-margin core brands and ongoing cost optimization initiatives.
2026-03-06 06:095d ago
2026-03-06 00:075d ago
US SEC drops Justin Sun lawsuit with $10M settlement from Rainberry
Justin has secured a $10 million settlement in a multi-year lawsuit filed by the United States Securities and Exchange Commission that accused the crypto entrepreneur of alleged fraud and securities violations.
Summary
Justin Sun settled the SEC’s long-running lawsuit with a $10 million payment from Rainberry, bringing an end to allegations tied to TRX and BTT token sales and trading practices. The case, originally filed in 2023 under former SEC Chair Gary Gensler, accused Sun and affiliated entities of unregistered securities sales. A letter from the SEC made public on Feb. 5 confirmed that neither Sun nor any of his companies involved in the case had admitted or denied the allegations, but the claims would be dropped following the payment of the fine.
With this, the SEC has wrapped up a three-year-long case that was filed under the leadership of former SEC Chair Gary Gensler, who was widely known for his regulation-by-enforcement approach.
Sun, along with affiliated entities including the Tron Foundation, BitTorrent Foundation, and Rainberry, was accused of selling unregistered securities involving TRX and BTT tokens. Further, the SEC alleged that Sun engaged in “manipulative wash trading” of TRX and paid celebrities like Akon, Lindsay Lohan, and Jake Paul to promote BTT without disclosing their compensation.
Sun has reiterated that the SEC’s complaints “lacks merit.”
Rainberry has agreed to pay a $10 million fine as part of the latest settlement.
“Today’s resolution brings closure, but I never stopped building. I will continue to focus on accelerating innovation in the United States and around the world, and look forward to working with the SEC to develop guidance and regulations for crypto going forward,” Sun wrote in a recent X post.
Justin Sun’s presidential ties under scrutiny The dismissal comes as no surprise because under President Donald Trump’s administration, the commission has taken a markedly pro-crypto stance and has dropped multiple enforcement actions that were previously brought against major industry players like Coinbase.
However, the decision to drop Sun’s case has also drawn scrutiny from some lawmakers, who believe the move may have been motivated by Sun’s financial ties to Trump-linked crypto ventures.
Soon after Trump’s election, Sun acquired $30 million worth of tokens linked to World Liberty Financial, which has direct links to the president’s family.
Democratic lawmakers, including Representatives Maxine Waters, Ritchie Torres, and Stephen Lynch, have argued that the circumstances surrounding the settlement warrant closer scrutiny and have requested the SEC to reopen the case.
Dogecoin corrected some gains and traded below $0.10 against the US Dollar. DOGE is now holding the $0.0920 support and might aim for a fresh increase.
DOGE price started a fresh downside correction below $0.10. The price is trading below the $0.0965 level and the 100-hourly simple moving average. There is a connecting bullish trend line forming with support at $0.0932 on the hourly chart of the DOGE/USD pair (data source from Kraken). The price could aim for a fresh increase if it remains stable above $0.0920. Dogecoin Price Dips Again Dogecoin price started a downside correction after it failed to stay above $0.1020, like Bitcoin and Ethereum. DOGE declined below the $0.10 and $0.0965 levels.
There was a move below the 50% Fib retracement level of the upward move from the $0.0885 swing low to the $0.1043 high. The price even spiked below $0.0950 before the bulls appeared. The price is now forming a base above $0.09320 and preparing for the next move.
There is also a connecting bullish trend line forming with support at $0.0932 on the hourly chart of the DOGE/USD pair. Dogecoin price is now trading above the $0.0935 level and the 100-hourly simple moving average. Immediate resistance on the upside is near the $0.0950 level.
Source: DOGEUSD on TradingView.com The first major resistance for the bulls could be near the $0.0978 level. The next major resistance is near the $0.10 level. A close above the $0.10 resistance might send the price toward $0.1050. Any more gains might send the price toward $0.1120. The next major stop for the bulls might be $0.1165.
Another Decline In DOGE? If DOGE’s price fails to climb above the $0.0950 level, it could continue to move down. Initial support on the downside is near the $0.0932 level.
The next major support is near the $0.0920 level or the 76.4% Fib retracement level of the upward move from the $0.0885 swing low to the $0.1043 high. The main support sits at $0.0880. If there is a downside break below the $0.0880 support, the price could decline further. In the stated case, the price might slide toward the $0.0820 level.
Technical Indicators
Hourly MACD – The MACD for DOGE/USD is now gaining momentum in the bearish zone.
Hourly RSI (Relative Strength Index) – The RSI for DOGE/USD is now below the 50 level.
Major Support Levels – $0.0.920 and $0.0880.
Major Resistance Levels – $0.0950 and $0.0978.
2026-03-06 06:095d ago
2026-03-06 00:145d ago
Arthur Hayes Says Rising Treasury Yields Could Trigger A Money-Printing Bailout And 'Benefit' Bitcoin
Arthur Hayes, Chief Investment Officer at Maelstrom Fund, told Benzinga on Thursday that rising oil prices and treasury yields could prove positive for Bitcoin (CRYPTO: BTC). What Treasury Yields Spike Amid War Means Hayes pointed out the surge in yields on the 10-year Treasury note, which is not typical in a “risk-off” scenario.
2026-03-06 06:095d ago
2026-03-06 00:205d ago
Ethereum Founder Vitalik Buterin Calls for Bold Rethink of Crypto Applications
TLDR: Vitalik Buterin calls for radical Ethereum application redesign while protecting core network security guarantees. Ethereum founder says AI may replace traditional crypto wallets and reshape how users interact with blockchain apps. Privacy now ranks alongside censorship resistance and security as a foundational Ethereum network principle. Buterin urges developers to rethink DeFi, oracles, and layer-2 roles using a first-principles approach. Ethereum co-founder Vitalik Buterin has urged developers to rethink how applications operate across the network.
He said Ethereum must remain firm on its core principles while exploring new approaches at the application layer. His comments point to changes in privacy, artificial intelligence integration, and decentralized finance design.
The remarks arrive as developers debate Ethereum’s long-term architecture and its relationship with emerging technologies.
Vitalik Buterin Pushes Ethereum Developers to Rethink Crypto Applications Buterin said Ethereum must keep its fundamental properties intact despite rapid technological shifts. He listed censorship resistance, open source development, privacy, and security as non-negotiable network principles.
He warned against uncertainty around the base layer’s guarantees. According to his post on X, developers must maintain trustless verification tools such as light clients.
I think it's healthy for us in the Ethereum world to have a more bold and open mindset to many things, particularly on the application layer and on how we see ourselves in the world.
We should not compromise on core properties: censorship resistance, open source, privacy,…
— vitalik.eth (@VitalikButerin) March 5, 2026
At the same time, he urged the community to adopt a more experimental approach to applications. Ethereum’s ecosystem, he said, should reconsider existing assumptions about user interfaces and platform design.
Artificial intelligence formed a central theme in his comments. Buterin suggested AI systems could replace traditional crypto wallet interfaces within a year.
He noted that AI tools may reshape how users interact with blockchain software. Instead of discrete applications, AI agents may guide users through a continuous interaction layer.
According to Buterin, such changes could transform how developers build services on Ethereum. Applications may become modular systems that users assemble dynamically.
Ethereum Privacy and Layer-2 Strategy Take Center Stage Buterin also emphasized the importance of privacy across Ethereum’s application stack. He said the ecosystem increasingly treats privacy as a core security property.
That shift could lead developers to rebuild large parts of the Ethereum software stack. Current infrastructure rarely prioritizes privacy at every layer.
He also pointed to growing work around private networking technologies. Several Ethereum Foundation initiatives focus on improving privacy across network communications.
Decentralized finance design also appeared in his discussion. Buterin suggested some DeFi systems could evolve into universal futures markets built on reliable decentralized oracles.
He proposed that oracles could combine cryptographic proofs with artificial intelligence models. These systems may verify data from trusted news sources using privacy-preserving technologies.
The Ethereum founder also encouraged the community to reconsider the role of layer-2 networks. He said developers should reassess which L2 designs best complement Ethereum’s base layer.
Buterin framed the discussion as a broader cultural shift within the ecosystem. Developers, he said, should challenge existing assumptions and rebuild applications from first principles.
2026-03-06 06:095d ago
2026-03-06 00:205d ago
Solana ETFs still hold ‘impressive numbers' even as token dives 57%
Bloomberg ETF analyst Eric Balchunas says Solana ETF inflows are posting “pretty impressive numbers,” even as the token has dropped by more than half since they launched.
Exchange-traded funds tied to Solana have held on to their early inflows, despite the token having more than halved in price since the funds were launched, which analysts say indicates institutional resilience.
Solana (SOL) is down 57% since Solana ETFs launched in the US in July, but the funds have managed to accumulate $1.5 billion in flows and “not really give any of it up,” Bloomberg ETF analyst Eric Balchunas said on Thursday.
He added that 50% of the inflows to the ETFs are from institutional investors, which Balchunas called a “serious investor base” and a good sign for the future.
Solana ETFs beat Bitcoin on market size basisBalchunas said that by adjusting Solana’s $50 billion market capitalization to Bitcoin’s (BTC), $1.4 trillion, Solana ETFs have seen the equivalent of $54 billion in net new flows, “which is about DOUBLE where Bitcoin was at the same point.”
Bitcoin had also gained in the months after Bitcoin ETFs were launched, compared to Solana’s price fall, which Balchunas said was “pretty impressive numbers given [the] size and condition of the underlying market.”
Solana ETFs hold on to gains as spot prices tank. Source: Eric Balchunas
Balchunas said that ETFs launching into that kind of market downturn usually make it “near impossible to get inflows.”
“Most wouldn’t even make it to age one or two if they went down 57% in the first six months,” he said. “Solana [is] defying physics here.”
Solana ETFs saw their first net outflow day in over a month on Thursday with $6 million exiting the six products, according to CoinGlass. It followed a big net inflow day on Wednesday when $19 million entered the products.
Solana down 70% from all-time highSolana hit an all-time high in January 2025 amid a memecoin minting frenzy that pushed the token to $293.
Today, it is 70% down from that peak, trading at around $88, having fallen 2.7% on the day and 11% over the past month, according to CoinGecko.
SOL has tanked almost 30% since the beginning of the year. Source: TradingView
Magazine: Would Bitcoin really be at $200K if not for Jane Street? Trade Secrets
Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy
Important DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted as, a recommendation or advice to take any action, including making any investment or purchasing any product. Before making any financial decision, you should conduct your own due diligence, exercise your own discretion, and consult with competent advisors. The content on this website is not personally directed to you, and we do not take into account your individual financial situation or needs. The information contained on this website is not necessarily provided in real time, nor is it guaranteed to be accurate. Prices displayed may be provided by market makers and not by exchanges. Any trading or other financial decision you make is entirely your own responsibility, and you must not rely solely on any information provided through the website. FXEmpire does not provide any warranty regarding the accuracy, completeness, or reliability of any information contained on the website and shall bear no responsibility for any trading losses you may incur as a result of using such information. The website may include advertisements and other promotional content. FXEmpire may receive compensation from third parties in connection with such content. FXEmpire does not endorse, recommend, or assume responsibility for the use of any third-party services or websites. Empire Media Network LTD., its employees, officers, subsidiaries, and affiliates shall not be liable for any loss or damage resulting from your use of the website or reliance on the information provided herein.Risk DisclaimersThis website contains information about cryptocurrencies, contracts for difference (CFDs), and other financial instruments, as well as about brokers, exchanges, and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and involve a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money. FX Empire encourages you to conduct your own research before making any investment decision and to avoid investing in any financial instrument unless you fully understand how it works and the risks involved.
2026-03-06 06:095d ago
2026-03-06 00:265d ago
Lyn Alden tips Bitcoin outperforming gold in next ‘two to three years'
Bitcoin is likely to outperform gold on price performance through to 2029 after gold’s strong recent rally, says macroeconomist Lyn Alden.
“If I had to bet Bitcoin versus gold over the next two to three years, I would bet Bitcoin,” Alden said on the New Era Finance podcast on Wednesday.
“Gun to my head, if I had to say which one I think outperforms, I would say Bitcoin,” she added.
“It's usually a pendulum between the two. If gold has gone up as much as it did, the entire diminishing return story per cycle is going to be erased in the coming one, too.”Many crypto industry executives, including Coinbase CEO Brian Armstrong, have predicted that Bitcoin (BTC) will reach $1 million by 2030 with clearer regulations taking shape in the US, which Armstrong called a “bellwether for the rest of the G20.”
Alden dismisses gold is in a bubbleBitcoin is often compared to gold as a hedge against inflation and economic uncertainty, with many investors dubbing it “digital gold.”
Alden said gold is seeing “somewhat euphoric” sentiment after it reached a new all-time high of around $5,608 in January.
“I wouldn’t say it’s a bubble, but it’s somewhat euphoric,” she said.
Lyn Alden was interviewed on the New Era Finance podcast this week. Source: New Era Finance podcastThe JM Bullion gold Fear and Greed Index, which tracks sentiment toward gold, posted a “Greed” score of 72 out of 100 on Friday. Meanwhile, on the same day, the Crypto Fear and Greed Index, which measures sentiment across Bitcoin and the broader crypto market, posted an “Extreme Fear” score of 18 out of 100.
Alden said that the sentiment toward Bitcoin is “somewhat unfairly negative.” Bitcoin is trading at $71,164, down 44% from its October all-time high of $126,000, according to CoinMarketCap.
Alden said she avoids relying too heavily on rigid narratives about the relationship between the two assets.
“I try to be hesitant about reading into how absolute these things are. Gold and Bitcoin can go up together, they can go down together,” she explained.
Investors debate Bitcoin’s narrativeWhile the two assets are often grouped together as alternatives to fiat currencies, the relationship isn’t always consistent; sometimes the prices move in tandem during periods of macro uncertainty, and other times they decouple.
Alden's comments come shortly after billionaire investor Ray Dalio warned against Bitcoin as a long-term store of value and safe-haven asset, arguing that it lacks central bank support and has lingering concerns about its privacy limitations and quantum resistance.
"Gold is not a precious metal that's speculated on,” Dalio said on Tuesday, adding it is the “most established money” that is the second-largest reserve asset held by central banks.
Meanwhile, CryptoQuant CEO Ki Young Ju said in October 2025 that Bitcoin’s correlation with gold is increasing as both assets strengthen their reputations as hedges against macroeconomic uncertainty.
Magazine: Bitcoin may face hard fork over any attempt to freeze Satoshi’s coins
Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy
2026-03-06 06:095d ago
2026-03-06 00:355d ago
Bitcoin and stocks stabilize after early-week slide. The bond market isn't convinced.
Bitcoin and stocks stabilize after early-week slide. The bond market isn’t convinced.Risk assets recover from oil-driven selloff as rising yields pressure Fed rate-cut bets. Mar 6, 2026, 5:35 a.m.
Bitcoin BTC$70,489.76 and global equity markets have stabilized after an early-week sell-off and oil price spike that was triggered by the outbreak of military conflict between the U.S., Israel, and Iran. Bond markets, however, are signaling caution, as rising yields signal renewed inflation concerns and dwindling bets on Fed rate cuts.
BTC, the leading cryptocurrency by market value, traded above $70,000 Friday, up nearly 10% for the week. Prices briefly climbed to nearly $74,000 Wednesday after dropping to around $65,000 over the weekend as geopolitical tensions rattled markets.
The rebound has been mirrored in equity futures. Contracts tied to the S&P 500 slid to a multi-week low of 6,718 points Tuesday before recovering to around 6,840 as of writing.
The initial risk-off move came as oil prices surged following reports that Iran had blocked oil tankers transiting through the Strait of Hormuz, a critical chokepoint for global crude supplies. Markets stabilized after the U.S. moved quickly to calm fears, promising naval escorts and political risk insurance for oil and gas tankers traveling through the strait.
Still, the bond market remains uneasy.
The yield on the 10-year U.S. Treasury note has risen for four consecutive days, climbing from 3.93% to 4.15%. Bond prices move inversely to yields. Meanwhile, the two-year yield, which is more sensitive to interest rate expectations, has jumped from 3.37% to nearly 3.60%.
The move higher in yields suggests traders are reassessing the outlook for monetary policy as the conflict-driven spike in energy prices threatens to rekindle inflation pressures.
According to CME Fed funds futures, investors now see less than a 50-50 chance of two 25-basis-point Fed rate cuts this year, down from nearly 80% before the onset of the conflict.
"The rates market is revealing the tension in this rally," Bryan Tan, trader at leading digital asset market maker Wintermute, said in an email, noting the rise in yields.
"The conflict between a resilient economy (ISM Services at 56.1, ADP at +63K vs +50K expected) and an inflationary energy shock is historically the kind of setup that keeps the Fed frozen for longer. The Warsh nomination officially hitting the Senate this week adds another layer of hawkish uncertainty," Tan added.
Some observers note that the inflationary impact of oil shocks typically unfolds gradually across the global economy, suggesting yields could remain elevated in the weeks ahead and potentially cap upside in risk assets such as stocks and cryptocurrencies.
"After major geopolitical shocks, oil prices usually rise gradually for weeks. The average pattern shows oil typically climbing 20–30% within ~60 days after the shock," analyst Jack Prandelli explained on X. "Markets often underprice the first phase of supply risk. The real move tends to happen once physical disruptions start showing up in flows and inventories."
Recent strong economic data in the U.S. has also contributed to the rise in yields and the scaling back of rate-cut expectations. Data released Tuesday showed economic activity in the U.S. services sector continued to expand in February, with the ISM index rising to 56.1. The ADP private payrolls report showed 63,000 job creations in February, the strongest reading since July 2025.
Attention now turns to Friday’s nonfarm payrolls report and wage growth figures. A hotter-than-expected print could further weaken expectations for Fed rate cuts and inject fresh volatility into financial markets.
More For You
CoinDesk Research looks into how Pudgy Penguins disrupts traditional toys market via a phygital model. With 2M+ units sold, they scale via global partnerships and events.
What to know:
Disrupting a Stagnant Market: Pudgy Penguins is utilizing a "Negative CAC" model to challenge the traditional $31.7B licensed toy industry by treating physical merchandise as a profitable user acquisition tool rather than just a final product.More For You
Almost nobody is talking about altseason anymore. That may be bullish
30 minutes ago
Social media mentions of "altseason" have dropped to their lowest level in two years, according to Santiment data, a contrarian signal that has preceded previous rallies in speculative crypto assets.
What to know:
Mentions of “altseason” on social media have plunged to their lowest level in at least two years, a sign of deep retail apathy that has historically preceded altcoin recoveries.Altcoins have sharply underperformed, with major tokens like Dogecoin, Solana and Cardano down 60% to 75% from recent peaks as capital has rotated into bitcoin and stablecoins.While on-chain data show large bitcoin holders accumulating, analysts say any altcoin rebound likely depends on bitcoin stabilizing amid broader market pressure from the Iran conflict.
2026-03-06 06:095d ago
2026-03-06 00:575d ago
Bitcoin relief rally faces headwinds as bear market persists: analysts
Bitcoin staged a brief relief rally above $74,000 on Thursday, but it has already petered out as analysts predict a persistent bear market will keep momentum subdued.
“Bitcoin is still in a bear market despite the recent rally,” on-chain analytics company CryptoQuant said on Thursday.
The platform’s Bull Score Index, a composite indicator that measures the overall health of Bitcoin (BTC) using a combination of fundamental and technical metrics, remains at 10 out of 100, “deep in bearish territory,” it said.
“Even after the recent price rally, fundamental and technical indicators still point to a bear market environment,” it stated.
“The current move is likely just a relief rally, not the start of a new bull phase.”Bitcoin briefly tapped a one-month high of $74,000 on Coinbase on Thursday, touching the 50-day exponential moving average, according to TradingView. However, it has already lost more than $3,000, falling back below $71,000 during Friday morning trading.
The Bull Score Index remains deep in bear territory. Source: CryptoQuantBitcoin still vulnerable to renewed downside pressureNick Ruck, the director of LVRG Research, told Cointelegraph that the crypto market’s recent relief rally came on “renewed risk appetite and ETF inflows,” but cautioned that the advance has “quickly faced headwinds with prices pulling back toward $71,000 amid persistent macro uncertainties and fading momentum.”
While the brief push provided a welcome relief rally amid supportive liquidity conditions, “ongoing bear market dynamics reinforce caution as softer macro signals, like the anticipated slowdown in February nonfarm payrolls, keep cryptocurrencies vulnerable to renewed downside pressure,” he said.
BTC quickly loses momentum, slipping 4.7% since Thursday’s high. Source: TradingViewBitcoin could see renewed buying interestCryptoQuant said that a positive Coinbase Premium has signaled renewed US buying interest, driving the recent rally.
Bitcoin spot demand from US-based investors also switched from contraction to growth, as seen by the Coinbase Bitcoin Premium “switching from deeply negative territory in early February to the most positive since October,” they said.
Selling pressure from traders and long-term holders has also eased after unrealized losses reached levels not seen since July 2022.
Meanwhile, analysts at SwissBlock observed on Friday that “momentum is flashing a critical shift,” adding “We’re exiting peak negative momentum, the kind of transition that often precedes a regime change.”
Magazine: Would Bitcoin really be at $200K if not for Jane Street? Trade Secrets
Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy